???global.info.a_carregar???
H-INDEX = 59 (SCOPUS/ResearcherID) or 68 (GoogleScholar) PUBLICATIONS: 215 publications in the fields of Human Genetics and Molecular Oncology Accumulated Impact Factor > 1.100,00 Work cited> 15.500 times C. Oliveira is recognized internationally for her work in E-cadherin/CDH1-related diseases and hereditary cancer. She disclosed novel germline causes of Hereditary Gastrointestinal Cancer and defined somatic events in tumours with impact for patient management and therapy. Her main scientific aim is to disclose the missing heritability in Hereditary Gastric Cancer. For this, her team is exploring the whole genome, with particular emphasis in its noncoding portion. She also aims at finding biomarkers with clinical utility for earlier detection of sporadic and hereditary gastric cancer and to disclose actionable genotype-phenotype relationships in these diseases. The social and economic impact of hereditary cancer is a transversal aspect in her research and she privileges the interaction with Patients associations, such as EVITA. C. Oliveira has been a PI of projects funded with >8M Euros and team member in projects with >3M Euros total budget. She independently raised additional 4M Euros for human resources. She was invited speaker in >150 National and International conferences; is the Secretary General of the Executive Committee of European Society of Human Genetics (ESHG), member of its Scientific Program Committee and President of the Portuguese Society of Human Genetics (SPGH); National Coordinator in the European Reference Network ERN-GENTURIS on genetic tumour risk syndromes, and; head the Hereditary Diffuse Gastric Cancer branch of the SolveRD (Solving Rare diseases) EU-Project. She is a founder member of the Portuguese Group of Hereditary Tumours (PROGO) promoted by The Portuguese Society of Oncology. She is regular reviewer of National and International fellowship and grant applications. She successfully supervised 16 Masters and 17 PhD students to completion, 12 post-docs and recruited 4 junior project leaders (iFCT and CEEC individual) for her team. C. Oliveira group has also gained expertise and visibility in genomics and bioinformatics, due to active participation in international consortia and large European Projects including the coordination of the 4.6M Euros project PREVENTABLE, membership in the the European-wide research project SOLVE-RD Solve Rare diseases; the Consortium GEUVADIS and GTEx; Several COST actions, as well as the Marie Sklodowska-Curie Innovative Training Networks ITN TRAIN-EV. The group has relevant roles in management and executive functions in the GenomePT National Infrastructure for genome sequencing and the 1 Million European Genomes project. Her group actively engages in networking activities promoting collaborations with researchers and hospitals worldwide. Examples of these networks are the European Reference Network on Tumours Risk Syndromes (ERN-GENTURIS), The SolveRD consortium; The Preventable consortium; TrainEV Marie Sklodowska-Curie Action; the IGCLC - International Gastric Cancer Linkage Consortium, and the CDH1 Variant Curation Expert Panel. Her team was awarded with the Prize Alfredo da Silva on Sustainability of health systems for the work on optimized pathways of care in Hereditary cancer syndromes; more recently her team was honorable mention in the "8th Edition Prémio Rui Osório de Castro / Millennium BCP" 2024 for the project "SAPO" Paediatric sarcomas and organoids: new diagnostic biomarkers; and awarded with the Prize Maria de Sousa 2023 on "Using Genome-Wide Crispr Genetic Screens to Dissect the Molecular Mechanisms Underlying Therapy Resistance and Sensitivity in Her2-Positive Gastric Cancer", by the Fundação Bial. C. Oliveira participated in more than 50 interviews/documentaries broadcasted on TV, Radio, Internet and Newspapers over the last 20 years.
Read full resume ↓
Identification

Personal identification

Full name
Carla Oliveira

Citation names

  • Oliveira, C

Author identifiers

Ciência ID
3011-EA6C-B5A3
ORCID iD
0000-0001-8340-2264
Researcher Id
F-8188-2011
Scopus Author Id
7102223149

Telephones

Telephone
  • 220408800 Ext.: 6173 (Professional)

Addresses

  • Lab 208S4 - i3S; Rua Alfredo Allen, 208, 4200-135 Porto, Portugal, 4200-135 , Porto, Porto, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences

Languages

Language Speaking Reading Writing Listening Peer-review
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
Spanish; Castilian Intermediate (B1) Intermediate (B1) Beginner (A1) Intermediate (B1)
Education
Degree Classification
2011 - 2012
Concluded
 Sabbatical fellowship (BSAB/1311870456/2011) Science and Technology Foundation (FCT), PT (Outros)
Fundação para a Ciência e a Tecnologia, Portugal
2005 - 2005
Concluded
 Travel fellowship from European Association for Cancer Research (EACR) to Vancouver, CA (Outros)
European Association For Cancer Research, United Kingdom
2004 - 2005
Concluded
 Postdoc fellow (D Huntsman’s lab) (Postgraduate Certificate)
Pathology Department-Laboratory Medicine, UBC, Canada
2002 - 2005
Concluded
 Post-doctoral fellowship (SFRH/BPD/9463/2002), FCT, PT (Pós-Graduação)
Fundação para a Ciência e a Tecnologia, Portugal
2002 - 2004
Concluded
 Postdoc fellow (R Seruca’s lab and Richard Hamelin’s lab), Ipatimup, Porto, PT & INSERM, Paris, FR (Pós-Graduação)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2000/09/01 - 2002/03/15
Concluded
 Visiting Ph.D. student at Ipatimup (Doutoramento)
Major in Human Genetics
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
1997/10/01 - 2002/03/15
Concluded
 Graduate Program on Basic and Applied Biology - GABBA PhD Program (Doutoramento)
Major in Biologia Humana
Universidade do Porto Faculdade de Medicina, Portugal
""Molecular genetic profiles of sporadic and familial gastric cancer: a study of microsatellite instability and E-cadherin"" (THESIS/DISSERTATION)
 Aprovada
1998/08/01 - 2000/08/31
Concluded
 Ph.D. student CIMR (Doctor of Philosophy)
Major in Human Genetics
University of Cambridge, United Kingdom
1997 - 1997
Concluded
 FCT Trainee fellowship (PRAXIS XXI), Cancer Genetics Group - Ipatimup, Porto, PT (Outros)
Fundação para a Ciência e a Tecnologia, Portugal
1995/09/01 - 1996/07/24
Concluded
 Degree Training at IBILI (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Identificação de mutações no gene da beta-MHC em doentes portugueses portadores de Miocardiopatia Hipertrófica Familiar" (THESIS/DISSERTATION)
 19
1991/09/01 - 1995/07/31
Concluded
 Biochemistry Degree (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
"Mutation screening of beta-myosin heavy chain gene in Portuguese kindred with Familial Hipertrofic Cardiomyopathy" (THESIS/DISSERTATION)
 13/20
Affiliation

Science

Category
Host institution 		Employer
2015 - Current Principal Investigator (Research) Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2013/01/01 - 2015/09/30 Principal Investigator (Research) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Other Careers

Category
Host institution 		Employer
2013 - 2023 Encarregado Geral Operacional (Assistente Operacional) Bioinf2Bio, Portugal

Others

Category
Host institution 		Employer
2023/01/01 - Current Permanent Position (Tenure) Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2006/12/01 - Current Affiliated Professor of Oncobiology, Pathology Dpt FMUP Universidade do Porto Faculdade de Medicina, Portugal
2005 - Current Consultant for cancer-associated syndromes, Ipatimup Diagnósticos Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2011/01/01 - 2022 Permanent position (Tenure) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2008/01/01 - 2012/12/31 Financially Independent Researcher – FCT Program Ciência 2007 Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2011/09/01 - 2012/09/01 Guest Scientist at E Izaurralde Lab, Max Planck Institute for Developmental Biology, Tuebingen, Germany (FCT - Sabbatical leave for 12 months) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Max Planck Institut für Entwicklungsbiologie Institut für Molekularbiologie, Germany
2005/07/01 - 2007/12/31 Project Leader at the Cancer Genetics Group (IDEIA Project funded by the Portuguese Innovation Agency) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2004/04/01 - 2005/06/30 Post-doc, British Columbia Cancer Agency, Vancouver, Canada British Columbia Cancer Agency, Vancouver, Canada, Canada
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2002/04/01 - 2004/03/01 Post-doc Fellow, Ipatimup (Porto, PT) & INSERM (Paris, FR) (FCT-fellowship) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
1997/10/01 - 2002/03/15 GABBA PhD student “Molecular genetic profile of sporadic and familial gastric cancer: A study of microsatellite instability and E-cadherin” supervised by Raquel Seruca and Carlos Caldas Universidade do Porto Faculdade de Medicina, Portugal
1997/02/01 - 1997/09/30 BIC Research Student in a FCT funded Project headed by Raquel Seruca “Screening of target genes somatic mutations in microsatellite unstable carcinomas” Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
1996/08/01 - 1996/12/31 Volunteer Research Student in a project headed by Carlos Faro on “Purification, Characterization and cDNA cloning of an aspartic proteinase from Cynara Humilis” CNC.IBILI, Portugal
1991/09/01 - 1996/07/24 Academic degree in Biochemistry with a Degree Training on “Mutation screening of beta-myosin heavy chain gene in Portuguese kindred with Familial Hipertrofic Cardiomyopathy” supervised by Carlos Faro Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
Projects

Grant

Designation Funders
2021 - Current Hereditary Breast Ovarian Cancer - HBOC: Optimizing hereditary cancer pathways (saving costs and lives). Alfredo da Silva Award 2021 on "Sustainability of Health Systems"
Sustainability of Health Systems
Principal investigator
Fundação Amélia de Mello, Portugal
 Fundação Amélia de Mello
Ongoing
2021 - Current CIA & EVITA Patients Association Grant for the project entitled “Hereditary Breast Ovarian Cancer – HBOC: Optimizing hereditary cancer pathways (saving costs and lives)”
C&A - EVITA
Principal investigator
EVITA - Associação de Apoio a Portadores de Alterações nos Genes Relacionados com Cancro Hereditário, Portugal
 EVITA - Associação de Apoio a Portadores de Alterações nos Genes Relacionados com Cancro Hereditário

C&A Industries LLC
Ongoing
2023/01/16 - 2024/07/15 DISCLOSING THE GENESIS OF HEREDITARY STOMACH CANCER THROUGH ORGAN-ON-A-CHIP TECHNOLOGY”. [DETONATE]
2022.02951.PTDC
Researcher
Fundação para a Ciência e a Tecnologia, I.P., Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing

Contract

Designation Funders
2023/01/01 - 2025/12/31 "CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE" [PREVENTABLE]
101095483
Principal investigator
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
 Horizon 2020
Ongoing
2018/01/01 - 2024/12/31 Solving The Unsolved Rare Diseases: Hereditary Gastric Cancer-SOLVE-RD
779257
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Horizon 2020
Ongoing
2021/03/31 - 2024/03/30 Life-time Risk Estimations and Genetic Modifiers Of Hereditary Diffuse Gastric Cancer - [LEGOH]
PTDC/BTM-TEC/6706/2020
Principal investigator
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
 Fundação para a Ciência e a Tecnologia
Ongoing
2020/11 - 2022/10 COVID-19 DRIVEN NEUROLOGICAL PHENOTYPES - [NeuroCovid]
NeuroCovid
NeuroCovid
Co-Principal Investigator (Co-PI)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 BIAL - PORTELA & C.ª, S.A
Concluded
2017/10/01 - 2022/04/30 Training In Extracellular Vesicles: For Benefit In Health & Disease-Train-EV
722148
Co-Principal Investigator (Co-PI)
Bioinf2Bio, Lda, Portugal
 Marie Sklodowska-Curie Innovative Training Networks
Concluded
2017/06/01 - 2021/12/13 National Laboratory For Genome Sequencing And Analysis-GenomePT
POCI-01-0145-FEDER-022184
22184
Co-Principal Investigator (Co-PI)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT

Programa Operacional Competitividade e Internacionalização, Programa Operacional Regional de Lisboa, Programa Operacional Regional do Algarve and by Fundação para a Ciência e a Tecnologia
Concluded
2018/03/05 - 2021/09/04 Long Survival In Patients With High-Grade Serous Carcinoma Of The Ovary: A Molecular And Clinical Study-OVARIO
OVARIO
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE
Concluded
2018/07/01 - 2021/06/30 Solving The 3D Chromatin Structure Of CDH1 Locus To Identify Disease-Associated Mechanisms - 3DCHROME
POCI-01-0145-FEDER-30164
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Concluded
2017/01/01 - 2020/12/31 WP3 - Principal Investigator - Csc Plasticity: Emt And Stem Cell State Generation From "Tackling Cancer Stem Cells: A Challenge And An Opportunity To Advance In Anti-Cancer Therapy-CANCERSTEM
POCI-01-0145-FEDER-016390
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Concluded
2016/02/01 - 2020/06/30 The Role Of Gastric Cancer Cell-Derived Extracellular Vesicles
GCEVs
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Ipatimup Board of Directors
Concluded
2016/05/01 - 2020/04/30 Diabetes & Obesity At The Crossroads Between Oncological And Cardiovascular Diseases – A System Analysis Nettwork Towards Precision Medicine-DOCnet
NORTE-01-0145-FEDER-000003
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Programa Operacional Regional do Norte
Concluded
2016/05/01 - 2019/12/31 WP1 - Principal Investigator - Mapping Genetic And Phenotypic Heterogeneity In Her2 Positive Cancers To Anticipate And Counteract Resistance Phenotypes
NORTE-01-0145-FEDER-000029
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Programa Operacional Regional do Norte
Concluded
2016/06/01 - 2019/12/01 A 3D microarray platform for the high-throughput analysis of the role of the extracellular matrix in cancer-associated epithelial-to-mesenchymal transitions
Provided by PTCRIS: 141144
PTDC/BBB-ECT/2518/2014
Co-Principal Investigator (Co-PI)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2016/02/01 - 2019/09/30 The Intronic Regulation of the CDH1 Gene
IntCDH1
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Ipatimup Board of Directors
Concluded
2014/01/01 - 2016/12/31 Defining The Contribution Of Mutations In CDH1 Non-Coding Regions And Other Known Susceptibility Genes To Hereditary Gastric Cancer
NSFC_2014
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 American association “NSFC - No Stomach for Cancer”
Concluded
2013/09/01 - 2016/11/30 Using NGS To Uncover Structural And Regulatory Variation In Gastric Cancer
NGSGC_2013
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Coimbra Genomics and BGI
Concluded
2012/03/01 - 2015/10/31 Adhesion, Differentiation and Invasion: different processes, common cadherin players
120049
Provided by PTCRIS: 120049
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2012/05/01 - 2015/08/31 TUMORTAG - Tumor-targeted nanoparticles for early diagnosis of gastric cancer
120958
Provided by PTCRIS: 120958
Co-Principal Investigator (Co-PI)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2011/04/01 - 2014/09/30 New E-cadherin RNAs: the dark side of a tumour suppressor gene
110785
Provided by PTCRIS: 110785
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2011/04/01 - 2014/09/30 Tumour spectrum in Hereditary Diffuse Gastric Cancer
110294
Provided by PTCRIS: 110294
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2010/05 - 2013/10 Functional genomics of ribosome infidelity phenotypes associated to human diseases.
98850
Provided by PTCRIS: 98850
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluded
2009/01/30 - 2012/07/29 Exploring the role of E-Cadherin-HER interaction in the search of molecular biomarkers for the clinical management of gastric cancer patients
Provided by PTCRIS: 82923
82923
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2008/07/01 - 2011/12/31 MLK3, a new mutated gene in MSI colorectal cancer
68310
Provided by PTCRIS: 68310
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2009/01 - 2011/12 Implementation of a Nacional Facility for DNA Microarrays: Phase II
64745
Provided by PTCRIS: 64745
Researcher
Universidade de Aveiro Centro de Estudos do Ambiente e do Mar, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2007/08 - 2010/11 Papel de novos mecanismos regulatórios na perda de expressão da caderina-E
72168
Provided by PTCRIS: 72168
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/07/01 - 2008/07/01 In mismatch repair deficiency colorectal cancer are BRAF and KRAS new prognostic and therapeutic tools?
56921
Provided by PTCRIS: 56921
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/07/01 - 2008/07/01 Identification of molecular mechanisms underlying gastric cancer in families positive and negative for E-cadherin germline mutations
58111
Provided by PTCRIS: 58111
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
2005/07 - 2008/06 Identification of signaling pathways involved in Cdx2 regulation in two human models of altered intestinal differentiation: intestinal metaplasia and juvenile polyposis.
55840
Provided by PTCRIS: 55840
Researcher
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Book chapter
  1. Irene Gullo; José Garcia-Pelaez; Rui Morais; Yuchun Ding; Carla Oliveira; Fátima Carneiro. "Histopathology of Hereditary Diffuse Gastric Cancer: From Grossing and 3D Microscopy to Immunophenotypic and Molecular Profiling". 2023.
    10.1007/978-3-031-21317-5_9
  2. Gianluca Tedaldi; Celina São José; Carla Oliveira. "Other Syndromes and Genes Associated with Gastric Cancer Predisposition". 2023.
    10.1007/978-3-031-21317-5_7
  3. Silvana Lobo; Paulo S. Pereira; Patrick R. Benusiglio; Carla Oliveira. "CTNNA1, a New HDGC Gene: Inactivating Mechanisms and Driven Phenotypes". 2023.
    10.1007/978-3-031-21317-5_5
  4. Gullo, Irene; Oliveira, Carla; van der Post, Rachel S.; van Dieren, Jolanda M.; Davis, Jeremy L.; Bougen-Zhukov, Nicola; Guilford, Parry; Carneiro, Fátima. "Updated perspective and directions on hereditary diffuse gastric cancer". In Research and Clinical Applications of Targeting Gastric Neoplasms, 217-258. Elsevier, 2021.
    10.1016/b978-0-323-85563-1.00011-3
  5. Carneiro, F; Guilford, P.; Oliveira C; van der Post RS. "Genetic tumour syndromes of the digestive system-Hereditary diffuse gastric cancer". In Molecular Pathology of Neoplastic Gastrointestinal Diseases, 535-538. WHO Classification of Tumours, 2019.
    Published
  6. Oliveira, C.; Pinheiro, H.; Figueiredo, J.; Seruca, R.; Carneiro, F.; Oliveira, Carla; Pinheiro, Hugo; et al. "E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer". In Prog Mol Biol Transl Sci, 337-359. Elsevier, 2013.
    Accepted • 10.1016/B978-0-12-394311-8.00015-7
  7. Leite, M.; Corso, G.; Sousa, S.; Carvalho, J.; Roviello, F.; Oliveira, C.; Figueiredo, C.; Seruca, R.. "Non- CDH1 -associated familial gastric cancer and epigenetics factors". In International Journal of Cancer. 2013.
    10.1007/978-94-007-6570-2_10
  8. Carvalho, J.; Pinheiro, H.; Oliveira, C.. "E-Cadherin germline mutations". In Molecular Pathology of Neoplastic Gastrointestinal Diseases. 2013.
    10.1007/978-94-007-6570-2_5
  9. Carvalho, J.; Pinheiro, H.; Oliveira, C.. "Alternative mechanisms to germline CDH1 mutations in hereditary diffuse gastric cancer". In Molecular Pathology of Neoplastic Gastrointestinal Diseases. 2013.
    10.1016/j.febslet.2012.07.045
  10. Carneiro, F; Oliveira C; Seruca, R. "Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes". In Molecular Pathology of Neoplastic Gastrointestinal Diseases, 83-107. United States: Springer, 2013.
    Published
  11. VELHO, SERGIA; Oliveira C; Raquel Seruca. "PIK3CA Gene Alterations in Human Cancers". In In Bioinformatics in Cancer and Cancer Therapy. Springer. Series: Cancer Drug Discovery and Development, 2009.
    Published
  12. Karam, R.; Oliveira C; Seruca, R; Carneiro, F. "Câncer Gástrico Hereditário". In Atualização em Câncer Gástrico. Portugal: Tecmedd, 2005.
    Published
Journal article
  1. Celina São José; José Garcia-Pelaez; Marta Ferreira; Oscar Arrieta; Ana André; Nelson Martins; Samantha Solís; et al. "Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer". Gastric Cancer (2023): http://dx.doi.org/10.1007/s10120-023-01395-0.
    10.1007/s10120-023-01395-0
  2. Catarina Guedes Vaz; Jéssica Rodrigues; Diogo Pereira; Ilda Matos; Carla Oliveira; Maria José Bento; Rui Magalhães; Manuel Correia; Luis Maia. "The crosstalk between Stroke and Cancer: Incidence of cancer after a first-ever cerebrovascular event in a population-based study". European Stroke Journal (2023): http://dx.doi.org/10.1177/23969873231181628.
    10.1177/23969873231181628
  3. Joana Guerra; Carla Pinto; Pedro Pinto; Manuela Pinheiro; Catarina Santos; Ana Peixoto; Carla Escudeiro; et al. "Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer". Cancers (2023): https://www.mdpi.com/2072-6694/15/17/4313.
    10.3390/cancers15174313
  4. Xi Luo; Jamie L Maciaszek; Bryony A Thompson; Huei San Leong; Katherine Dixon; Sónia Sousa; Michael Anderson; et al. "Optimising clinical care throughCDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines". Journal of Medical Genetics (2023): http://dx.doi.org/10.1136/jmg-2022-108807.
    10.1136/jmg-2022-108807
  5. Maqueda, Joaquín J.; Giovanazzi, Alberta; Rocha, Ana Mafalda; Rocha, Sara; Silva, Isabel; Saraiva, Nadine; Bonito, Nuno; et al. "Adapter dimer contamination in sRNA-sequencing datasets predicts sequencing failure and batch effects and hampers extracellular vesicle-sRNA analysis". Journal of Extracellular Biology 2 6 (2023): http://dx.doi.org/10.1002/jex2.91.
    10.1002/jex2.91
  6. Celina São José; Carla Pereira; Marta Ferreira; Ana André; Hugo Osório; Irene Gullo; Fátima Carneiro; Carla Oliveira. "3D Chromatin Architecture Re-Wiring at the CDH3/CDH1 Loci Contributes to E-Cadherin to P-Cadherin Expression Switch in Gastric Cancer". Biology (2023): https://doi.org/10.3390/biology12060803.
    10.3390/biology12060803
  7. Joaquín J. Maqueda; Mafalda Santos; Marta Ferreira; Sérgio Marinho; Sara Rocha; Mafalda Rocha; Nadine Saraiva; et al. "NGS Data Repurposing Allows Detection of tRNA Fragments as Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles". International Journal of Molecular Sciences 24 10 (2023): 8961. https://doi.org/10.3390/ijms24108961.
    Published • 10.3390/ijms24108961
  8. Yaldiz, Burcu; Kucuk, Erdi; Hampstead, Juliet; Hofste, Tom; Pfundt, Rolph; Corominas Galbany, Jordi; Rinne, Tuula; et al. "Twist exome capture allows for lower average sequence coverage in clinical exome sequencing". Human Genomics 17 1 (2023): http://dx.doi.org/10.1186/s40246-023-00485-5.
    10.1186/s40246-023-00485-5
  9. Denommé-Pichon, Anne-Sophie; Matalonga, Leslie; de Boer, Elke; Jackson, Adam; Benetti, Elisa; Banka, Siddharth; Bruel, Ange-Line; et al. "A Solve-RD ClinVar-based reanalysis of 1522 index cases from ERN-ITHACA reveals common pitfalls and misinterpretations in exome sequencing". Genetics in Medicine 25 4 (2023): 100018. http://dx.doi.org/10.1016/j.gim.2023.100018.
    10.1016/j.gim.2023.100018
  10. Francesca Forzano; Olga Antonova; Angus Clarke; Guido de Wert; Sabine Hentze; Yalda Jamshidi; Yves Moreau; et al. "Correction to: Reply to Letter by Tellier et al., ‘Scientific refutation of ESHG statement on embryo selection’". European Journal of Human Genetics (2023): http://dx.doi.org/10.1038/s41431-022-01263-y.
    10.1038/s41431-022-01263-y
  11. Francesca Forzano; Olga Antonova; Angus Clarke; Guido de Wert; Sabine Hentze; Yalda Jamshidi; Yves Moreau; et al. "Reply to Letter by Tellier et al., ‘Scientific refutation of ESHG statement on embryo selection’". European Journal of Human Genetics (2023): http://dx.doi.org/10.1038/s41431-022-01241-4.
    10.1038/s41431-022-01241-4
  12. Garcia-Pelaez, José; Barbosa-Matos, Rita; Lobo, Silvana; Dias, Alexandre; Garrido, Luzia; Castedo, Sérgio; Sousa, Sónia; et al. "Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes". The Lancet Oncology 24 1 (2023): 91-106. http://dx.doi.org/10.1016/s1470-2045(22)00643-x.
    Open access • 10.1016/s1470-2045(22)00643-x
  13. Daniel A. Ferreira; João P. Conde; Mario Rothbauer; Peter Ertl; Pedro L. Granja; Carla Oliveira. "Bioinspired human stomach-on-a-chip with in vivo like function and architecture". Lab on a Chip (2023): https://doi.org/10.1039/D2LC01132H.
    10.1039/D2LC01132H
  14. Linda Hendricks; Nicoline Hoogerbrugge; Hanka Venselaar; Stefan Aretz; Isabel Spier; Eric Legius; Hilde Brems; et al. "Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort". European Journal of Medical Genetics (2022): http://dx.doi.org/10.1016/j.ejmg.2022.104632.
    10.1016/j.ejmg.2022.104632
  15. Jihenne BEN AISSA-HAJ; Hugo Pinheiro; François Cornelis; Molka Sebai; Didier Meseure; Adrien Briaux; Philippe Berteaux; et al. "The Identification of Large Rearrangements Involving Intron 2 of the CDH1 Gene in BRCA1/2 Negative and Breast Cancer Susceptibility". Genes (2022): https://www.mdpi.com/2073-4425/13/12/2213.
    10.3390/genes13122213
  16. Francesca Forzano; Olga Antonova; Angus Clarke; Guido de Wert; Sabine Hentze; Yalda Jamshidi; Yves Moreau; et al. "Correction: The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice". European Journal of Human Genetics (2022): http://dx.doi.org/10.1038/s41431-022-01155-1.
    10.1038/s41431-022-01155-1
  17. Coudert, Marie; Drouet, Youenn; Delhomelle, Hélène; Svrcek, Magali; Benusiglio, Patrick R; Coulet, Florence; Clark, Dana Farengo; et al. "First estimates of diffuse gastric cancer risks for carriers ofCTNNA1germline pathogenic variants". Journal of Medical Genetics 59 12 (2022): 1189-1195. http://dx.doi.org/10.1136/jmg-2022-108740.
    10.1136/jmg-2022-108740
  18. Mafalda Santos; Marta Ferreira; Patrícia Oliveira; Nuno Mendes; Ana André; André F. Vieira; Joana B. Nunes; et al. "Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFß1 Promotes Tumour Growth". Biology (2022): https://www.mdpi.com/2079-7737/11/7/1046.
    10.3390/biology11071046
  19. Santos, Mafalda; Fidalgo, Ana; Varanda, Ana Sofia; Soares, Ana Raquel; Almeida, Gabriela M.; Martins, Diana; Mendes, Nuno; Oliveira, Carla; Santos, Manuel A. S.. "Upregulation of tRNA-Ser-AGA-2-1 Promotes Malignant Behavior in Normal Bronchial Cells". Frontiers in Molecular Biosciences 9 (2022): http://dx.doi.org/10.3389/fmolb.2022.809985.
    10.3389/fmolb.2022.809985
  20. Sommer, Anna K.; te Paske, Iris B.A.W.; Garcia-Pelaez, José; Laner, Andreas; Holinski-Feder, Elke; Steinke-Lange, Verena; Peters, Sophia; et al. "Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes– a collaborative multicentre endeavour within the project Solve-RD". European Journal of Medical Genetics 65 5 (2022): 104475. http://dx.doi.org/10.1016/j.ejmg.2022.104475.
    10.1016/j.ejmg.2022.104475
  21. Francesca Forzano; Olga Antonova; Angus Clarke; Guido de Wert; Sabine Hentze; Yalda Jamshidi; Yves Moreau; et al. "The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice". European Journal of Human Genetics (2022): http://dx.doi.org/10.1038/s41431-021-01000-x.
    10.1038/s41431-021-01000-x
  22. Baião, Ana; Dias, Sofia; Soares, Ana Francisca; Pereira, Catarina Leite; Oliveira, Carla; Sarmento, Bruno. "Advances in the use of 3D colorectal cancer models for novel drug discovery". Expert Opinion on Drug Discovery 17 6 (2022): 569-580. http://dx.doi.org/10.1080/17460441.2022.2056162.
    10.1080/17460441.2022.2056162
  23. José Garcia-Pelaez; Rita Barbosa-Matos; Celina São José; Sónia Sousa; Irene Gullo; Nicoline Hoogerbrugge; Fátima Carneiro; Carla Oliveira. "Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes". European Journal of Medical Genetics (2022): https://doi.org/10.1016/j.ejmg.2021.104401.
    10.1016/j.ejmg.2021.104401
  24. Oliveira, C; Park, Ji-Hyeon; Campelos, Sofia; Gullo, Irene; Lemos, Carolina; Solorzano, Leslie; Martins, Diana; et al. "Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness". International Journal of Cancer 150 5 (2021): 868-880. http://dx.doi.org/10.1002/ijc.33872.
    10.1002/ijc.33872
  25. Silvana Lobo; Patrick R. Benusiglio; Florence Coulet; Lise Boussemart; Lisa Golmard; Isabel Spier; Robert Hüneburg; et al. "Cancer predisposition and germline CTNNA1 variants". European Journal of Medical Genetics 64 10 (2021): 104316-104316. https://doi.org/10.1016/j.ejmg.2021.104316.
    10.1016/j.ejmg.2021.104316
  26. Barbosa-Matos, Rita; Leal Silva, Rafaela; Garrido, Luzia; Aguiar, Ana Cerqueira; Garcia-Pelaez, José; André, Ana; Seixas, Susana; et al. "The CDH1 c.1901C to T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing". Cancers 13 17 (2021): 4464. http://dx.doi.org/10.3390/cancers13174464.
    10.3390/cancers13174464
  27. Gabriela M Almeida; Carla Pereira; Ji-Hyeon Park; Carolina Lemos; Sofia Campelos; Irene Gullo; Diana Martins; et al. "CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients". Biomedicines (2021): https://www.mdpi.com/2227-9059/9/9/1249.
    10.3390/biomedicines9091249
  28. "Solving patients with rare diseases through programmatic reanalysis of genome-phenome data". European Journal of Human Genetics 29 9 (2021): 1337-1347. http://dx.doi.org/10.1038/s41431-021-00852-7.
    10.1038/s41431-021-00852-7
  29. "Correction to: Solve-RD: systematic pan-European data sharing and collaborative analysis to solve rare diseases". European Journal of Human Genetics 29 9 (2021): 1459-1461. http://dx.doi.org/10.1038/s41431-021-00936-4.
    10.1038/s41431-021-00936-4
  30. "Correction: Solving unsolved rare neurological diseases—a Solve-RD viewpoint". European Journal of Human Genetics 29 9 (2021): 1462-1465. http://dx.doi.org/10.1038/s41431-021-00935-5.
    10.1038/s41431-021-00935-5
  31. Leslie Matalonga; Carles Hernandez-Ferrer; Davide Piscia; Enzo Cohen; Isabel Cuesta; Daniel Danis; Anne-Sophie Denommé-Pichon; et al. "Correction to: Solving patients with rare diseases through programmatic reanalysis of genome-phenome data". European Journal of Human Genetics (2021): http://dx.doi.org/10.1038/s41431-021-00934-6.
    10.1038/s41431-021-00934-6
  32. Iris B. A. W. te Paske; José Garcia-Pelaez; Anna Katharina Sommer; Leslie Matalonga; Teresa Starzynska; Anna Jakubowska; Laura Valle; et al. "A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report". European Journal of Human Genetics (2021): http://dx.doi.org/10.1038/s41431-021-00853-6.
    10.1038/s41431-021-00853-6
  33. Ana R. Bezerra; Carla Oliveira; Inês Correia; Ana Rita Guimarães; Gonçalo Sousa; Maria João Carvalho; Gabriela Moura; Manuel A S Santos. "The role of non-standard translation in Candida albicans pathogenesis". FEMS Yeast Research (2021): http://dx.doi.org/10.1093/femsyr/foab032.
    10.1093/femsyr/foab032
  34. José Garcia-Pelaez; Rita Barbosa-Matos; Irene Gullo; Fátima Carneiro; Carla Oliveira. "Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges". Molecular Oncology (2021): https://doi.org/10.1002/1878-0261.12948.
    10.1002/1878-0261.12948
  35. Gianluca Tedaldi; chiara molinari; Celina São José; Rita Barbosa-Matos; Ana André; rita danesi; Valentina Arcangeli; et al. "Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer". Pharmaceuticals (2021): https://www.mdpi.com/1424-8247/14/5/457.
    10.3390/ph14050457
  36. Daniel A. Ferreira; Mario Rothbauer; João P. Conde; Peter Ertl; Carla Oliveira; Pedro L. Granja. "A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators". Advanced Science (2021): 2003273-2003273. https://doi.org/10.1002/advs.202003273.
    10.1002/advs.202003273
  37. Leslie Solorzano; Carla Pereira; Diana Martins; Raquel Almeida; Fatima Carneiro; Gabriela M. Almeida; Carla Oliveira; Carolina Wahlby. "Towards Automatic Protein Co-Expression Quantification in Immunohistochemical TMA Slides". IEEE Journal of Biomedical and Health Informatics 25 2 (2021): 393-402. https://doi.org/10.1109/JBHI.2020.3008821.
    10.1109/JBHI.2020.3008821
  38. Bianca N. Lourenço; Rúben F. Pereira; Cristina C. Barrias; Claudia Fischbach; Carla Oliveira; Pedro L. Granja. "Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells". Nanomaterials (2021): https://doi.org/10.3390/nano11020295.
    10.3390/nano11020295
  39. Hugo Osório; Cátia Silva; Marta Ferreira; Irene Gullo; Valdemar Máximo; Rita Barros; Fernando Mendonça; Carla Oliveira; Fátima Carneiro. "Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus". Journal of Clinical Medicine (2021): https://doi.org/10.3390/jcm10030407.
    10.3390/jcm10030407
  40. Sara Rocha; Afonso P Basto; Marieke E Ijsselsteijn; Sara Pinto Teles; Maria M Azevedo; Gilza Gonçalves; Irene Gullo; et al. "Immunophenotype of Gastric Tumors Unveils a Pleiotropic Role of Regulatory T Cells in Tumor Development". Cancers (2021): https://www.mdpi.com/2072-6694/13/3/421.
    10.3390/cancers13030421
  41. D. Gareth Evans; Emma R. Woodward; Svetlana Bajalica-Lagercrantz; Carla Oliveira; Thierry Frebourg. "Germline TP53 Testing in Breast Cancers: Why, When and How?". Cancers 12 12 (2020): 3762-3762. https://doi.org/10.3390/cancers12123762.
    10.3390/cancers12123762
  42. Magenheim, R.; Frebourg, T.; Lagercrantz, S.; Olivera, C.; Evans, G.R.. "1937P ERN GENTURIS guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes". Annals of Oncology 31 (2020): S1095. http://dx.doi.org/10.1016/j.annonc.2020.08.1330.
    10.1016/j.annonc.2020.08.1330
  43. Lobo, Silvana; Pereira, Carla; Oliveira, Carla; Almeida, Gabriela M.; Silvana Lobo; Carla Pereira; Carla Oliveira; Gabriela M. Almeida. "Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells". Cancers 12 9 (2020): 2378. http://dx.doi.org/10.3390/cancers12092378.
    10.3390/cancers12092378
  44. Frebourg, Thierry; Lagercrantz, Svetlana Bajalica; Oliveira, Carla; Magenheim, Rita; Evans, D. Gareth; Hoogerbrugge, Nicoline; Ligtenberg, Marjolijn; et al. "Reply to Kratz et al.". European Journal of Human Genetics 28 11 (2020): 1483-1485. http://dx.doi.org/10.1038/s41431-020-00710-y.
    10.1038/s41431-020-00710-y
  45. Blair, Vanessa R; McLeod, Maybelle; Carneiro, Fátima; Coit, Daniel G; D'Addario, Johanna L; van Dieren, Jolanda M; Harris, Kirsty L; et al. "Hereditary diffuse gastric cancer: updated clinical practice guidelines". The Lancet Oncology 21 8 (2020): e386-e397. http://dx.doi.org/10.1016/s1470-2045(20)30219-9.
    10.1016/s1470-2045(20)30219-9
  46. Sousa, Abel; Ferreira, Marta; Oliveira, Carla; Ferreira, Pedro G.. "Gender Differential Transcriptome in Gastric and Thyroid Cancers". Frontiers in Genetics 11 (2020): http://dx.doi.org/10.3389/fgene.2020.00808.
    10.3389/fgene.2020.00808
  47. Gullo, Irene; Costa, Catarina; Silva, Susana L.; Ferreira, Cristina; Motta, Adriana; Silva, Sara P.; Ferreira, Rúben Duarte; et al. "The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer". Cells 9 6 (2020): 1498. http://dx.doi.org/10.3390/cells9061498.
    10.3390/cells9061498
  48. Tischkowitz, Marc; Colas, Chrystelle; Pouwels, Sjaak; Hoogerbrugge, Nicoline. "Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome". European Journal of Human Genetics 28 10 (2020): 1387-1393. http://dx.doi.org/10.1038/s41431-020-0651-7.
    10.1038/s41431-020-0651-7
  49. Carla Pereira; Daniel Ferreira; Nuno Mendes; Pedro L. Granja; Gabriela M. Almeida; Carla Oliveira; Pereira, Carla; et al. "Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells". Cancers 12 4 (2020): 858. https://doi.org/10.3390/cancers12040858.
    10.3390/cancers12040858
  50. Devezas, Vítor; Baptista, Manuela; Gullo, Irene; Rocha, João; Sousa, Fabiana; Xiaogang, Wen; Preto, John; et al. "Risk-reducing total gastrectomy in asymptomatic CDH1 carriers". European Surgery (2020): http://dx.doi.org/10.1007/s10353-020-00630-7.
    10.1007/s10353-020-00630-7
  51. Carvalho, Joana; Oliveira, Patricia; Senz, Janine; São José, Celina; Hansford, Samantha; Teles, Sara Pinto; Ferreira, Marta; et al. "Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives". Journal of Medical Genetics (2020): jmedgenet-2019. http://dx.doi.org/10.1136/jmedgenet-2019-106346.
    10.1136/jmedgenet-2019-106346
  52. Leclercq, Philippe; Jadot, Virginie; Bours, Vincent; Oliveira, Carla; Neumann, Helmut; Bisschops, Raf. "Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch?". Therapeutic Advances in Gastroenterology 13 (2020): 175628482091639. http://dx.doi.org/10.1177/1756284820916399.
    10.1177/1756284820916399
  53. Ana Baião; Flávia Sousa; Ana Vanessa Oliveira; Carla Oliveira; Bruno Sarmento. "Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells". Biomaterials Science (2020): https://doi.org/10.1039/D0BM00556H.
    10.1039/D0BM00556H
  54. Sara Pinto Teles; Patrícia Oliveira; Marta Ferreira; Joana Carvalho; Pedro Ferreira; Carla Oliveira. "Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer". Cancers 12 1 (2019): 70-70. https://doi.org/10.3390/cancers12010070.
    10.3390/cancers12010070
  55. Carneiro, Patrícia; Moreira, Ana Margarida; Figueiredo, Joana; Barros, Rita; Oliveira, Patrícia; Fernandes, Maria Sofia; Ferro, Anabela; et al. "S100P is a molecular determinant of E-cadherin function in gastric cancer". Cell Communication and Signaling 17 1 (2019): http://dx.doi.org/10.1186/s12964-019-0465-9.
    10.1186/s12964-019-0465-9
  56. Varanda, Ana Sofia; Santos, Mafalda; Soares, Ana R.; Vitorino, Rui; Oliveira, Patrícia; Oliveira, Carla; Santos, Manuel A. S.. "Human cells adapt to translational errors by modulating protein synthesis rate and protein turnover". RNA Biology 17 1 (2019): 135-149. http://dx.doi.org/10.1080/15476286.2019.1670039.
    10.1080/15476286.2019.1670039
  57. Gianluca Tedaldi; Francesca Pirini; Michela Tebaldi; Valentina Zampiga; Ilaria Cangini; Rita Danesi; Valentina Arcangeli; et al. "Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition". Cancers (2019): https://www.mdpi.com/2072-6694/11/9/1340.
    10.3390/cancers11091340
  58. Dueñas, Marta; Pérez-Figueroa, Andrés; Oliveira, Carla; Suárez-Cabrera, Cristian; Sousa, Abel; Oliveira, Patricia; Villacampa, Felipe; Paramio, Jesús M.; Martínez-Fernández, Mónica. "Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status". Scientific Reports 9 1 (2019): http://dx.doi.org/10.1038/s41598-019-46652-4.
    10.1038/s41598-019-46652-4
  59. Santos, Mafalda; Fidalgo, Ana; Varanda, A. Sofia; Oliveira, Carla; Santos, Manuel A.S.. "tRNA Deregulation and Its Consequences in Cancer". Trends in Molecular Medicine (2019): http://dx.doi.org/10.1016/j.molmed.2019.05.011.
    10.1016/j.molmed.2019.05.011
  60. Sara Rocha; Sara Pinto Teles; Mafalda Azevedo; Patrícia Oliveira; Joana Carvalho; Carla Oliveira; Rocha, Sara; et al. "Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner". International Journal of Molecular Sciences 20 11 (2019): 2608-2608. https://doi.org/10.3390/ijms20112608.
    10.3390/ijms20112608
  61. Härkönen, Kai; Oikari, Sanna; Kyykallio, Heikki; Capra, Janne; Hakkola, Sini; Ketola, Kirsi; Thanigai Arasu, Uma; et al. "CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells". Cells 8 3 (2019): 276. http://dx.doi.org/10.3390/cells8030276.
    10.3390/cells8030276
  62. Bustos-Carpinteyro, Andrea Rebeca; Oliveira, Carla; Sousa, Abel; Oliveira, Patricia; Pinheiro, Hugo; Carvalho, Joana; Magaña-Torres, María Teresa; et al. "CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer". BMC Cancer 19 1 (2019): http://dx.doi.org/10.1186/s12885-019-5294-0.
    10.1186/s12885-019-5294-0
  63. van der Post, R.S.; Oliveira, C.; Guilford, P.; Carneiro, F.. "Hereditary gastric cancer: what’s new? Update 2013–2018". Familial Cancer 18 3 (2019): 363-367. http://www.scopus.com/inward/record.url?eid=2-s2.0-85064713408&partnerID=MN8TOARS.
    10.1007/s10689-019-00127-7
  64. Oliveira, C.; Sousa, M.. "The effects of L-carnitine supplementation in athletic performance,Les effets d'un complément alimentaire en L-carnitine dans la performance sportive". Science and Sports 34 2 (2019): 63-72. http://www.scopus.com/inward/record.url?eid=2-s2.0-85058374734&partnerID=MN8TOARS.
    10.1016/j.scispo.2018.09.005
  65. Slavin, T.P.; Weitzel, J.N.; Neuhausen, S.L.; Schrader, K.A.; Oliveira, C.; Karam, R.. "Genetics of gastric cancer: What do we know about the genetic risks?". Translational Gastroenterology and Hepatology 4 July (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85070982425&partnerID=MN8TOARS.
    10.21037/tgh.2019.07.02
  66. Rocha, Sara; Carvalho, Joana; Oliveira, Patrícia; Voglstaetter, Maren; Schvartz, Domitille; Thomsen, Andreas R.; Walter, Nadia; et al. "3D Cellular Architecture Affects MicroRNA and Protein Cargo of Extracellular Vesicles". Advanced Science 6 4 (2018): 1800948. http://dx.doi.org/10.1002/advs.201800948.
    10.1002/advs.201800948
  67. Pereira C; Ferreira D; Lemos C; Martins D; Mendes N; Almeida D; Granja P; et al. "CD44v6 expression is a novel predictive marker of therapy response and poor prognosis in gastric cancer patients". BioRxiv (2018): http://europepmc.org/abstract/PPR/PPR63343.
    Accepted • 10.1101/468934
  68. Kennedy, Patrick J.; Sousa, Flavia; Ferreira, Daniel; Pereira, Carla; Nestor, Marika; Oliveira, Carla; Granja, Pedro L.; et al. "Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6". Acta Biomaterialia 81 (2018): 208-218. http://dx.doi.org/10.1016/j.actbio.2018.09.043.
    10.1016/j.actbio.2018.09.043
  69. Vos, Janet R.; Giepmans, Lisette; Röhl, Claas; Geverink, Nicoline; Hoogerbrugge, Nicoline; Oliveira, Carla. "Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes". Familial Cancer 18 2 (2018): 281-284. http://dx.doi.org/10.1007/s10689-018-0110-6.
    10.1007/s10689-018-0110-6
  70. Rocha, João P; Gullo, Irene; Wen, Xiaogang; Devezas, Vítor; Baptista, Manuela; Oliveira, Carla; Carneiro, Fátima; et al. "Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management". Histopathology 73 6 (2018): 878-886. http://dx.doi.org/10.1111/his.13715.
    10.1111/his.13715
  71. Lourenço BN; Dos Santos T; Oliveira C; Barrias CC; Granja PL; Lourenço, Bianca N.; dos Santos, Tiago; et al. "Bioengineering a novel 3D in vitro model of gastric mucosa for stomach permeability studies.". Acta biomaterialia 82 (2018): 68-78. http://europepmc.org/abstract/med/30308252.
    10.1016/j.actbio.2018.10.007
  72. Gullo, Irene; Carvalho, Joana; Martins, Diana; Lemos, Diana; Monteiro, Ana; Ferreira, Marta; Das, Kakoli; et al. "The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors". International Journal of Molecular Sciences 19 7 (2018): 2079. http://dx.doi.org/10.3390/ijms19072079.
    10.3390/ijms19072079
  73. Lima JF; Carvalho J; Pinto-Ribeiro I; Almeida C; Wengel J; Cerqueira L; Figueiredo C; et al. "Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides.". BMC molecular biology 19 1 (2018): http://europepmc.org/abstract/med/29879907.
    10.1186/s12867-018-0107-6
  74. Santos M; Pereira PM; Varanda AS; Carvalho J; Azevedo M; Mateus DD; Mendes N; et al. "Codon misreading tRNAs promote tumor growth in mice.". RNA biology (2018): http://europepmc.org/abstract/med/29558247.
    10.1080/15476286.2018.1454244
  75. Kennedy, Patrick J.; Perreira, Ines; Ferreira, Daniel; Nestor, Marika; Oliveira, Carla; Granja, Pedro L.; Sarmento, Bruno; et al. "Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles". European Journal of Pharmaceutics and Biopharmaceutics 127 (2018): 366-370. http://dx.doi.org/10.1016/j.ejpb.2018.03.005.
    10.1016/j.ejpb.2018.03.005
  76. Gullo, Irene; Oliveira, Patrícia; Athelogou, Maria; Gonçalves, Gilza; Pinto, Marta L.; Carvalho, Joana; Valente, Ana; et al. "New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression". Gastric Cancer 22 1 (2018): 77-90. http://dx.doi.org/10.1007/s10120-018-0836-8.
    10.1007/s10120-018-0836-8
  77. Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo. "Anti-miRNA oligonucleotides: A comprehensive guide for design". RNA Biology 15 3 (2018): 338-352. https://doi.org/10.1080/15476286.2018.1445959.
    10.1080/15476286.2018.1445959
  78. Ferreira PG; Muñoz-Aguirre M; Reverter F; Sá Godinho CP; Sousa A; Amadoz A; Sodaei R; et al. "The effects of death and post-mortem cold ischemia on human tissue transcriptomes.". Nature communications 9 1 (2018): http://europepmc.org/abstract/med/29440659.
    10.1038/s41467-017-02772-x
  79. Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; et al. "Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.". Gastrointestinal endoscopy 87 6 (2018): 1566-1575. http://europepmc.org/abstract/med/29454568.
    10.1016/j.gie.2018.02.008
  80. Weren, Robbert D A; van der Post, Rachel S; Vogelaar, Ingrid P; van Krieken, J Han; Spruijt, Liesbeth; Lubinski, Jan; Jakubowska, Anna; et al. "Role of germline aberrations affecting CTNNA1, MAP3K6 and MYD88 in gastric cancer susceptibility". Journal of Medical Genetics 55 10 (2018): 669-674. http://dx.doi.org/10.1136/jmedgenet-2017-104962.
    10.1136/jmedgenet-2017-104962
  81. Bianca N. Lourenço; Nora L. Springer; Daniel Ferreira; Carla Oliveira; Pedro L. Granja; Claudia Fischbach; Lourenço, Bianca N.; et al. "CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling". Integrative Biology 10 3 (2018): 145-158. https://doi.org/10.1039/C7IB00179G.
    10.1038/srep27072
  82. Lee, K.; Krempely, K.; Roberts, M.E.; Anderson, M.J.; Carneiro, F.; Chao, E.; Dixon, K.; et al. "Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants". Human Mutation 39 11 (2018): 1553-1568. http://www.scopus.com/inward/record.url?eid=2-s2.0-85054665075&partnerID=MN8TOARS.
    10.1002/humu.23650
  83. França, M.; Martí-Bonmatí, L.; Silva, S.; Oliveira, C.; Alberich Bayarri, Á.; Vilas Boas, F.; Pessegueiro-Miranda, H.; Porto, G.. "Optimizing the management of hereditary haemochromatosis: the value of MRI R2* quantification to predict and monitor body iron stores". British Journal of Haematology 183 3 (2018): 491-493. http://www.scopus.com/inward/record.url?eid=2-s2.0-85032351854&partnerID=MN8TOARS.
    10.1111/bjh.14982
  84. Solorzano, L.; Almeida, G.M.; Mesquita, B.; Martins, D.; Oliveira, C.; Wählby, C.. "Whole Slide Image Registration for the Study of Tumor Heterogeneity". Lecture Notes in Computer Science, Springer 11039 LNCS (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85053920196&partnerID=MN8TOARS.
    Accepted • 10.1007/978-3-030-00949-6_12
  85. Kennedy, P.J.; Oliveira, C.; Granja, P.L.; Sarmento, B.. "Monoclonal antibodies: technologies for early discovery and engineering". Critical Reviews in Biotechnology 38 3 (2018): 394-408. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027194652&partnerID=MN8TOARS.
    10.1080/07388551.2017.1357002
  86. Gullo, I.; Carneiro, F.; Oliveira, C.; Almeida, G.M.. "Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications". Pathobiology 85 1-2 (2018): 50-63. http://www.scopus.com/inward/record.url?eid=2-s2.0-85021073873&partnerID=MN8TOARS.
    10.1159/000473881
  87. Dias, J.R.; Baptista-Silva, S.; Oliveira, C.M.T.D.; Sousa, A.; Oliveira, A.L.; Bártolo, P.J.; Granja, P.L.. "In situ crosslinked electrospun gelatin nanofibers for skin regeneration". European Polymer Journal 95 (2017): 161-173. http://www.scopus.com/inward/record.url?eid=2-s2.0-85026912199&partnerID=MN8TOARS.
    10.1016/j.eurpolymj.2017.08.015
  88. Vogelaar, I.P.; Van Der Post, R.S.; Van Krieken, J.H.J.M.; Spruijt, L.; Van Zelst-Stams, W.A.G.; Kets, C.M.; Lubinski, J.; et al. "Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing". European Journal of Human Genetics 25 11 (2017): 1246-1252. http://www.scopus.com/inward/record.url?eid=2-s2.0-85031288768&partnerID=MN8TOARS.
    10.1038/ejhg.2017.138
  89. Kennedy, P.J.; Oliveira, C.; Granja, P.L.; Sarmento, B.. "Antibodies and associates: Partners in targeted drug delivery". Pharmacology and Therapeutics 177 (2017): 129-145. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016399420&partnerID=MN8TOARS.
    10.1016/j.pharmthera.2017.03.004
  90. Laundos, T.L.; Silva, J.; Assunção, M.; Quelhas, P.; Monteiro, C.; Oliveira, C.; Oliveira, M.J.; Pêgo, A.P.; Amaral, I.F.. "Rotary orbital suspension culture of embryonic stem cell-derived neural stem/progenitor cells: impact of hydrodynamic culture on aggregate yield, morphology and cell phenotype". Journal of Tissue Engineering and Regenerative Medicine 11 8 (2017): 2227-2240. http://www.scopus.com/inward/record.url?eid=2-s2.0-84975769766&partnerID=MN8TOARS.
    10.1002/term.2121
  91. Korsak, B.; Almeida, G.M.; Rocha, S.; Pereira, C.; Mendes, N.; Osório, H.; Pereira, P.M.R.; et al. "Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer". International Journal of Cancer 141 7 (2017): 1478-1489. http://www.scopus.com/inward/record.url?eid=2-s2.0-85022335625&partnerID=MN8TOARS.
    10.1002/ijc.30844
  92. Bidarra, S. J.; Oliveira, P.; Rocha, S.; Saraiva, D. P.; Oliveira, C.; Barrias, C. C.. "A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion". Scientific Reports 6 1 (2016): http://dx.doi.org/10.1038/srep27072.
    10.1038/srep27072
  93. Vogelaar, I.P.; Ligtenberg, M.J.L.; van der Post, R.S.; de Voer, R.M.; Kets, C.M.; Jansen, T.J.G.; Jacobs, L.; et al. "Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect". Familial Cancer 15 2 (2016): 289-296. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951853036&partnerID=MN8TOARS.
    10.3402/jev.v5.32538
  94. Martins-Marques, T.; Pinho, M.J.; Zuzarte, M.; Oliveira, C.; Pereira, P.; Sluijter, J.P.G.; Gomes, C.; Girao, H.. "Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin". Journal of Extracellular Vesicles 5 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-85015307223&partnerID=MN8TOARS.
    10.3402/jev.v4.27066
  95. van der Post, R.S.; Gullo, I.; Oliveira, C.; Tang, L.H.; Grabsch, H.I.; O’Donovan, M.; Fitzgerald, R.C.; van Krieken, H.; Carneiro, F.. "Histopathological, molecular, and genetic profile of hereditary diffuse gastric cancer: Current knowledge and challenges for the future". Adv Exp Med Biol 908 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84985019015&partnerID=MN8TOARS.
    Accepted • 10.1016/j.bbadis.2015.07.001
  96. Fais, S.; O'Driscoll, L.; Borras, F.E.; Buzas, E.; Camussi, G.; Cappello, F.; Carvalho, J.; et al. "Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine". ACS Nano 10 4 (2016): 3886-3899. http://www.scopus.com/inward/record.url?eid=2-s2.0-84968866526&partnerID=MN8TOARS.
    10.1021/acsnano.5b08015
  97. Oliveira, P.; Carvalho, J.; Rocha, S.; Azevedo, M.; Reis, I.; Camilo, V.; Sousa, B.; et al. "Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation". Scientific Reports 6 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84990946691&partnerID=MN8TOARS.
    10.1038/srep34860
  98. Magalhães, Ana; Marcos-Pinto, Ricardo; Nairn, Alison V.; dela Rosa, Mitche; Ferreira, Rui M.; Junqueira-Neto, Susana; Freitas, Daniela; et al. "Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852 9 (2015): 1928-1939. http://dx.doi.org/10.1016/j.bbadis.2015.07.001.
    10.1016/j.bbadis.2015.07.001
  99. Oliveira, Carla; Pinheiro, Hugo; Figueiredo, Joana; Seruca, Raquel; Carneiro, Fátima; Oliveira, C.; Pinheiro, H.; et al. "Familial gastric cancer: genetic susceptibility, pathology, and implications for management". The Lancet Oncology 16 2 (2015): e60-e70. http://dx.doi.org/10.1016/s1470-2045(14)71016-2.
    10.1016/s1470-2045(14)71016-2
  100. Yáñez-Mó, M.; Siljander, P.R.-M.; Andreu, Z.; Zavec, A.B.; Borràs, F.E.; Buzas, E.I.; Buzas, K.; et al. "Biological properties of extracellular vesicles and their physiological functions". Journal of Extracellular Vesicles 4 2015 (2015): 1-60. http://www.scopus.com/inward/record.url?eid=2-s2.0-85014619748&partnerID=MN8TOARS.
    10.3389/fimmu.2014.00685
  101. Caires, H.R.; Gomez-Lazaro, M.; Oliveira, C.M.; Gomes, D.; Mateus, D.D.; Oliveira, C.; Barrias, C.C.; Barbosa, M.A.; Almeida, C.R.. "Finding and tracing human MSC in 3D microenvironments with the photoconvertible protein Dendra2". Scientific Reports 5 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84929376876&partnerID=MN8TOARS.
    10.1007/s10689-015-9859-z
  102. Carvalho, J.; Oliveira, C.. "Extracellular Vesicles - Powerful markers of cancer EVolution". Frontiers in Immunology 6 JAN (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84926638210&partnerID=MN8TOARS.
    10.1007/978-3-319-41388-4_18
  103. Hansford, S.; Kaurah, P.; Li-Chang, H.; Woo, M.; Senz, J.; Pinheiro, H.; Schrader, K.A.; et al. "Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond". JAMA Oncology 1 1 (2015): 23-32. http://www.scopus.com/inward/record.url?eid=2-s2.0-84989787164&partnerID=MN8TOARS.
    10.1001/jamaoncol.2014.168
  104. van der Post, R.S.; Vogelaar, I.P.; Carneiro, F.; Guilford, P.; Huntsman, D.; Hoogerbrugge, N.; Caldas, C.; et al. "Hereditary diffuse gastric cancer: Updated clinical guidelines with an emphasis on germline CDH1 mutation carriers". Journal of Medical Genetics 52 6 (2015): 361-374. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930650698&partnerID=MN8TOARS.
    10.1136/jmedgenet-2015-103094
  105. Pinheiro, H.; Oliveira, P.; Oliveira, C.. "Hereditary cancer risk assessment: Challenges for the next-gen sequencing era". Frontiers in Oncology 5 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-85011344593&partnerID=MN8TOARS.
    10.3389/fonc.2015.00062
  106. Alves, S.; Castro, L.; Fernandes, M.S.; Francisco, R.; Castro, P.; Priault, M.; Chaves, S.R.; et al. "Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy". Oncotarget 6 31 (2015): 30787-30802. http://www.scopus.com/inward/record.url?eid=2-s2.0-84945530861&partnerID=MN8TOARS.
    10.18632/oncotarget.5021
  107. Queirós, P.; Pinheiro, H.; Carvalho, J.; Oliveira, P.; Gullo, I.; Carneiro, F.; Almeida, G.M.; Oliveira, C.. "KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity". Virchows Archiv 467 4 (2015): 383-392. http://www.scopus.com/inward/record.url?eid=2-s2.0-84944513629&partnerID=MN8TOARS.
    10.1007/s00428-015-1823-7
  108. Pinheiro, Hugo; Oliveira, Carla; Seruca, Raquel; Carneiro, Fátima. "Hereditary diffuse gastric cancer – Pathophysiology and clinical management". Best Practice & Research Clinical Gastroenterology 28 6 (2014): 1055-1068. http://dx.doi.org/10.1016/j.bpg.2014.09.007.
    10.1016/j.bpg.2014.09.007
  109. Bordeira-Carriço, R.; Ferreira, D.; Mateus, D.D.; Pinheiro, H.; Pêgo, A.P.; Santos, M.A.S.; Oliveira, C.. "Rescue of wild-type E-cadherin expression from nonsense-mutated cancer cells by a suppressor-tRNA". European Journal of Human Genetics 22 9 (2014): 1085-1092. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906269658&partnerID=MN8TOARS.
    10.1038/ejhg.2013.292
  110. Durães, C.; Almeida, G.M.; Seruca, R.; Oliveira, C.; Carneiro, F.. "Biomarkers for gastric cancer: Prognostic, predictive or targets of therapy?". Virchows Archiv 464 3 (2014): 367-378. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897048556&partnerID=MN8TOARS.
    10.1007/s00428-013-1533-y
  111. Carneiro, F.; Wen, X.; Seruca, R.; Oliveira, C.. "Familial gastric carcinoma". Diagnostic Histopathology 20 6 (2014): 239-246. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901696919&partnerID=MN8TOARS.
    10.1016/j.mpdhp.2014.03.010
  112. Gaston, D.; Hansford, S.; Oliveira, C.; Nightingale, M.; Pinheiro, H.; Macgillivray, C.; Kaurah, P.; et al. "Germline Mutations in MAP3K6 Are Associated with Familial Gastric Cancer". PLoS Genetics 10 10 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908327625&partnerID=MN8TOARS.
    10.1371/journal.pgen.1004669
  113. Maciel, J.; Oliveira, M.I.; Colton, E.; McNally, A.K.; Oliveira, C.; Anderson, J.M.; Barbosa, M.A.. "Adsorbed fibrinogen enhances production of bone- and angiogenic-related factors by monocytes/macrophages". Tissue Engineering - Part A 20 1-2 (2014): 250-263. http://www.scopus.com/inward/record.url?eid=2-s2.0-84891526984&partnerID=MN8TOARS.
    10.1089/ten.tea.2012.0439
  114. Fernandes, R.; Amador, P.; Oliveira, C.; Prudêncio, C.. "Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal". The Scientific World Journal 2014 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84896122819&partnerID=MN8TOARS.
    10.1155/2014/782897
  115. De-Freitas-Junior, J.C.M.; Carvalho, S.; Dias, A.M.; Oliveira, P.; Cabral, J.; Seruca, R.; Oliveira, C.; et al. "Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. An interplay with E-cadherin". PLoS ONE 8 11 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84896731020&partnerID=MN8TOARS.
    10.1371/journal.pone.0081579
  116. Fernandes, M.S.; Carneiro, F.; Oliveira, C.; Seruca, R.. "Colorectal cancer and RASSF family-A special emphasis on RASSF1A". International Journal of Cancer 132 2 (2013): 251-258. http://www.scopus.com/inward/record.url?eid=2-s2.0-84869503619&partnerID=MN8TOARS.
    10.1002/ijc.27696
  117. Oliveira, C.; Seruca, R.; Hoogerbrugge, N.; Ligtenberg, M.; Carneiro, F.. "Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC)". European Journal of Human Genetics 21 8 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84880922499&partnerID=MN8TOARS.
    10.1038/ejhg.2012.247
  118. Pereira, B.; Sousa, S.; Barros, R.; Carreto, L.; Oliveira, P.; Oliveira, C.; Chartier, N.T.; et al. "CDX2 regulation by the RNA-binding protein MEX3A: Impact on intestinal differentiation and stemness". Nucleic Acids Research 41 7 (2013): 3986-3999. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876542486&partnerID=MN8TOARS.
    10.1093/nar/gkt087
  119. Carneiro, P.; Figueiredo, J.; Bordeira-Carriço, R.; Fernandes, M.S.; Carvalho, J.; Oliveira, C.; Seruca, R.. "Therapeutic targets associated to E-cadherin dysfunction in gastric cancer". Expert Opinion on Therapeutic Targets 17 10 (2013): 1187-1201. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884582960&partnerID=MN8TOARS.
    10.1517/14728222.2013.827174
  120. Corso, Giovanni; Carvalho, Joana; Marrelli, Daniele; Vindigni, Carla; Carvalho, Beatriz; Seruca, Raquel; Roviello, Franco; et al. "Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer". Journal of Clinical Oncology 31 7 (2013): 868-875. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=CCC&KeyUT=CCC:000315447200015&KeyUID=CCC:000315447200015.
    10.1200/JCO.2012.44.4612
  121. Pinho, Salome S.; Carvalho, Sandra; Marcos-Pinto, Ricardo; Magalhaes, Ana; Oliveira, Carla; Gu, Jianguo; Dinis-Ribeiro, Mario; et al. "Gastric cancer: adding glycosylation to the equation". Trends in Molecular Medicine 19 11 (2013): 664-676. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000327923500003&KeyUID=WOS:000327923500003.
    10.1016/j.molmed.2013
  122. Paredes, Joana; Figueiredo, Joana; Albergaria, André; Oliveira, Patrícia; Carvalho, Joana; Ribeiro, Ana Sofia; Caldeira, Joana; et al. "Epithelial E- and P-cadherins: Role and clinical significance in cancer". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826 2 (2012): 297-311. http://dx.doi.org/10.1016/j.bbcan.2012.05.002.
    10.1016/j.bbcan.2012.05.002
  123. Pinho, S.S.; Oliveira, P.; Cabral, J.; Carvalho, S.; Huntsman, D.; Gärtner, F.; Seruca, R.; Reis, C.A.; Oliveira, C.. "Loss and recovery of Mgat3 and GnT-III mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-Mesenchymal-Epithelial transitions". PLoS ONE 7 3 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84858138360&partnerID=MN8TOARS.
    10.1136/gutjnl-2011-300427
  124. Kluijt, I.; Siemerink, E.J.M.; Ausems, M.G.E.M.; Van Os, T.A.M.; De Jong, D.; Simões-Correia, J.; Van Krieken, J.H.; et al. "CDH1-related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling". International Journal of Cancer 131 2 (2012): 367-376. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860833106&partnerID=MN8TOARS.
    10.1038/sj.onc.1207061
  125. Caldeira, J.; Simões-Correia, J.; Paredes, J.; Pinto, M.T.; Sousa, S.; Corso, G.; Marrelli, D.; et al. "CPEB1, a novel gene silenced in gastric cancer: A Drosophila approach". Gut 61 8 (2012): 1115-1123. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863719147&partnerID=MN8TOARS.
    10.1002/ijc.26398
  126. Pinheiro, H.; Carvalho, J.; Oliveira, P.; Ferreira, D.; Pinto, M.T.; Osoquot;rio, H.; Licastro, D.; et al. "Transcription initiation arising from E-cadherin/CDH1 intron2: A novel protein isoform that increases gastric cancer cell invasion and angiogenesis". Human Molecular Genetics 21 19 (2012): 4253-4269. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866408689&partnerID=MN8TOARS.
    10.1093/hmg/dds248
  127. Bordeira-Carriço, R.; Pêgo, A.P.; Santos, M.; Oliveira, C.. "Cancer syndromes and therapy by stop-codon readthrough". Trends in Molecular Medicine 18 11 (2012): 667-678. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868212770&partnerID=MN8TOARS.
    10.1097/00125480-200211000-00001
  128. Oliveira, P.; Sanges, R.; Huntsman, D.; Stupka, E.; Oliveira, C.. "Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators". European Journal of Human Genetics 20 8 (2012): 878-883. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864135719&partnerID=MN8TOARS.
    10.1053/gast.2001.28000
  129. Lopes, Nair; Carvalho, Joana; Duraes, Cecilia; Sousa, Barbara; Gomes, Madalena; Costa, Jose Luis; Oliveira, Carla; et al. "1Alpha,25-dihydroxyvitamin D(3) Induces de novo E-cadherin Expression in Triple-negative Breast Cancer Cells by CDH1-promoter Demethylation". Anticancer Research 32 1 (2012): 249-257. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000298780700005&KeyUID=WOS:000298780700005.
  130. Carvalho, Joana; van Grieken, Nicole C; Pereira, Patricia M; Sousa, Sónia; Tijssen, Marianne; Buffart, Tineke E; Diosdado, Begoña; et al. "Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer". The Journal of Pathology (2012): n/a-n/a. http://dx.doi.org/10.1002/path.4032.
    10.1002/path.4032
  131. Leite, M.; Corso, G.; Sousa, S.; Milanezi, F.; Afonso, L.P.; Henrique, R.; Soares, J.M.; et al. "MSI phenotype and MMR alterations in familial and sporadic gastric cancer". International Journal of Cancer 128 7 (2011): 1606-1613. http://www.scopus.com/inward/record.url?eid=2-s2.0-79551478326&partnerID=MN8TOARS.
    10.1002/ijc.25495
  132. Corso, G.; Pedrazzani, C.; Pinheiro, H.; Fernandes, E.; Marrelli, D.; Rinnovati, A.; Pascale, V.; et al. "E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer". European Journal of Cancer 47 4 (2011): 631-639. http://www.scopus.com/inward/record.url?eid=2-s2.0-79851510776&partnerID=MN8TOARS.
    10.1038/ejhg.2012.11
  133. Corso, G.; Velho, S.; Paredes, J.; Pedrazzani, C.; Martins, D.; Milanezi, F.; Pascale, V.; et al. "Oncogenic mutations in gastric cancer with microsatellite instability". European Journal of Cancer 47 3 (2011): 443-451. http://www.scopus.com/inward/record.url?eid=2-s2.0-79251593630&partnerID=MN8TOARS.
    10.1016/j.ejca.2010.09.008
  134. Svrcek, M.; Buhard, O.; Colas, C.; Coulet, F.; Dumont, S.; Massaoudi, I.; Lamri, A.; et al. "Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: An initiating step in the development of mismatch repair-deficient colorectal cancers". Gut 59 11 (2010): 1516-1526. http://www.scopus.com/inward/record.url?eid=2-s2.0-78049517419&partnerID=MN8TOARS.
    10.1002/path.4032
  135. Pinheiro, H.; Bordeira-Carriço, R.; Seixas, S.; Carvalho, J.; Senz, J.; Oliveira, P.; Inácio, P.; et al. "Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer". Human Molecular Genetics 19 5 (2010): 943-952. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950533734&partnerID=MN8TOARS.
    10.1093/hmg/ddp537
  136. Velho, S.; Oliveira, C.; Paredes, J.; Sousa, S.; Leite, M.; Matos, P.; Milanezi, F.; et al. "Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours". Human Molecular Genetics 19 4 (2010): 697-706. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950353937&partnerID=MN8TOARS.
    10.1093/hmg/ddp536
  137. Da Cunha, C.B.; Oliveira, C.; Wen, X.; Gomes, B.; Sousa, S.; Suriano, G.; Grellier, M.; et al. "De novo expression of CD44 variants in sporadic and hereditary gastric cancer". Laboratory Investigation 90 11 (2010): 1604-1614. http://www.scopus.com/inward/record.url?eid=2-s2.0-78049336816&partnerID=MN8TOARS.
    10.1038/labinvest.2010.155
  138. Albergaria, A.; Ribeiro, A.S.; Pinho, S.; Milanezi, F.; Carneiro, V.; Sousa, B.; Sousa, S.; et al. "ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: A role for C/EBPß in CDH3 gene activation". Human Molecular Genetics 19 13 (2010): 2554-2566. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954172745&partnerID=MN8TOARS.
    10.1093/hmg/ddq134
  139. Velho, S.; Corso, G.; Oliveíra, C.; Seruca, R.. "KRAS Signaling Pathway Alterations in Microsatellite Unstable Gastrointestinal Cancers". Adv Cancer Research 109 (2010): 123-143. http://www.scopus.com/inward/record.url?eid=2-s2.0-78149389848&partnerID=MN8TOARS.
    Accepted • 10.1016/B978-0-12-380890-5.00004-1
  140. Carneiro, Fatima; Oliveira, Carla; Seruca, Raquel; Carneiro, F.; Oliveira, C.; Seruca, R.. "Pathology and Genetics of Familial Gastric Cancer". International Journal of Surgical Pathology 18 3 (2010): 33S-36S. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000277605200004&KeyUID=WOS:000277605200004.
    10.1177/1066896910366463
  141. Fitzgerald RC; Hardwick R; Huntsman D; Carneiro F; Guilford P; Blair V; Chung DC; et al. "Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.". (2010): http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000279326400002&KeyUID=WOS:000279326400002.
    10.1136/jmg.2009.074237
  142. Melo, S.A.; Ropero, S.; Moutinho, C.; Aaltonen, L.A.; Yamamoto, H.; Calin, G.A.; Rossi, S.; et al. "Erratum: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function (Nature Genetics (2009) 41 (365-370))". Nature Genetics 42 5 (2010): 464-464. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951723098&partnerID=MN8TOARS.
    10.1038/ng0510-464b
  143. Velho, S.; Oliveira, C.; Seruca, R.. "KRAS mutations and anti-epidermal growth factor receptor therapy in colorectal cancer with lymph node metastases". Journal of Clinical Oncology 27 1 (2009): 158-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-58149327464&partnerID=MN8TOARS.
    10.1200/JCO.2008.20.1525
  144. Borie, C.; Colas, C.; Dartigues, P.; Lazure, T.; Rince, P.; Buhard, O.; Folliot, P.; et al. "The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms". International Journal of Cancer 125 10 (2009): 2360-2366. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349861911&partnerID=MN8TOARS.
    10.1002/ijc.24681
  145. Pinto, C.; Veiga, I.; Pinheiro, M.; Peixoto, A.; Pinto, A.; Lopes, J.M.; Reis, R.M.; et al. "TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset". Familial Cancer 8 4 (2009): 383-390. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449519172&partnerID=MN8TOARS.
    10.1007/s10689-009-9251-y
  146. Oliveira, C.; Sousa, S.; Pinheiro, H.; Karam, R.; Bordeira-Carriço, R.; Senz, J.; Kaurah, P.; et al. "Quantification of Epigenetic and Genetic 2nd Hits in CDH1 During Hereditary Diffuse Gastric Cancer Syndrome Progression". Gastroenterology 136 7 (2009): 2137-2148. http://www.scopus.com/inward/record.url?eid=2-s2.0-66149108352&partnerID=MN8TOARS.
    10.1053/j.gastro.2009.02.065
  147. Pereira, B.; Oliveira, C.; David, L.; Almeida, R.. "CDX2 promoter methylation is not associated with mRNA expression". International Journal of Cancer 125 7 (2009): 1739-1742. http://www.scopus.com/inward/record.url?eid=2-s2.0-68549086983&partnerID=MN8TOARS.
    10.1002/ijc.24544
  148. Oliveira, C.; Senz, J.; Kaurah, P.; Pinheiro, H.; Sanges, R.; Haegert, A.; Corso, G.; et al. "Germline CDH1 deletions in hereditary diffuse gastric cancer families". Human Molecular Genetics 18 9 (2009): 1545-1555. http://www.scopus.com/inward/record.url?eid=2-s2.0-64549109715&partnerID=MN8TOARS.
    10.1093/hmg/ddp046
  149. Oliveira, C.; Seruca, R.; Carneiro, F.. "Hereditary gastric cancer". Best Practice and Research: Clinical Gastroenterology 23 2 (2009): 147-157. http://www.scopus.com/inward/record.url?eid=2-s2.0-65349162141&partnerID=MN8TOARS.
    10.1016/j.bpg.2009.02.003
  150. Seruca, R.; Velho, S.; Oliveira, C.; Leite, M.; Matos, P.; Jordan, P.. "Unmasking the role of KRAS and BRAF pathways in MSI colorectal tumors.". Expert Rev Gastroenterol Hepatol 3 1 (2009): 5-9. http://www.ncbi.nlm.nih.gov/pubmed/19210107.
    10.1586/17474124.3.1.5 [pii]10.1586/17474124.3.1.5
  151. Gonçalves, C. M.; Castro, M. A.; Henriques, T.; Oliveira, M. I.; Pinheiro, H. C.; Oliveira, C.; Sreenu, V. B.; et al. "Molecular cloning and analysis of SSc5D, a new member of the scavenger receptor cysteine-rich superfamily.". Mol Immunol 46 13 (2009): 2585-96. http://www.ncbi.nlm.nih.gov/pubmed/19535143.
    S0161-5890(09)00223-5 [pii]10.1016/j.molimm.2009.05.006
  152. Melo, S.A.; Ropero, S.; Moutinho, C.; Aaltonen, L.A.; Yamamoto, H.; Calin, G.A.; Rossi, S.; et al. "A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function". Nature Genetics 41 3 (2009): 365-370. http://www.scopus.com/inward/record.url?eid=2-s2.0-61349127117&partnerID=MN8TOARS.
    10.1038/ng.317
  153. Velho, S.; Moutinho, C.; Cirnes, L.; Albuquerque, C.; Hamelin, R.; Schmitt, F.; Carneiro, F.; Oliveira, C.; Seruca, R.. "BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?". BMC Cancer 8 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-53149097362&partnerID=MN8TOARS.
    10.1186/1471-2407-8-255
  154. Karam, R.; Carvalho, J.; Bruno, I.; Graziadio, C.; Senz, J.; Huntsman, D.; Carneiro, F.; et al. "The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers". Oncogene 27 30 (2008): 4255-4260. http://www.scopus.com/inward/record.url?eid=2-s2.0-47049115051&partnerID=MN8TOARS.
    10.1038/onc.2008.62
  155. Barber, M.; Murrell, A.; Ito, Y.; Maia, A.-T.; Hyland, S.; Oliveira, C.; Save, V.; et al. "Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer". Journal of Pathology 216 3 (2008): 295-306. http://www.scopus.com/inward/record.url?eid=2-s2.0-55249091627&partnerID=MN8TOARS.
    10.1002/path.2426
  156. Matos, P.; Oliveira, C.; Velho, S.; Gonçalves, V.; da Costa, L.T.; Moyer, M.P.; Seruca, R.; Jordan, P.. "B-RafV600ECooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival". Gastroenterology 135 3 (2008): 899-906. http://www.scopus.com/inward/record.url?eid=2-s2.0-51249098983&partnerID=MN8TOARS.
    10.1053/j.gastro.2008.05.052
  157. Simões-Correia, J.; Figueiredo, J.; Oliveira, C.; van Hengel, J.; Seruca, R.; van Roy, F.; Suriano, G.. "Endoplasmic reticulum quality control: A new mechanism of E-cadherin regulation and its implication in cancer". Human Molecular Genetics 17 22 (2008): 3566-3576. http://www.scopus.com/inward/record.url?eid=2-s2.0-54949124637&partnerID=MN8TOARS.
    10.1093/hmg/ddn249
  158. Woo, M.M.M.; Salamanca, C.M.; Miller, M.; Symowicz, J.; Leung, P.C.K.; Oliveira, C.; Ehlen, T.G.; et al. "Serous borderline ovarian tumors in long-term culture: Phenotypic and genotypic distinction from invasive ovarian carcinomas". International Journal of Gynecological Cancer 18 6 (2008): 1234-1247. http://www.scopus.com/inward/record.url?eid=2-s2.0-55949097629&partnerID=MN8TOARS.
    10.1111/j.1525-1438.2007.01171.x
  159. Carneiro, F.; Oliveira, C.; Leite, M.; Seruca, R.. "Molecular targets and biological modifiers in gastric cancer". Seminars in Diagnostic Pathology 25 4 (2008): 274-287. http://www.scopus.com/inward/record.url?eid=2-s2.0-53749100421&partnerID=MN8TOARS.
    10.1053/j.semdp.2008.07.004
  160. Preto, A.; Figueiredo, J.; Velho, S.; Ribeiro, A.S.; Soares, P.; Oliveira, C.; Seruca, R.. "BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600Ebut not KRAS mutations". Journal of Pathology 214 3 (2008): 320-327. http://www.scopus.com/inward/record.url?eid=2-s2.0-38949208776&partnerID=MN8TOARS.
    10.1002/path.2295
  161. Carneiro, F.; Oliveira, C.; Suriano, G.; Seruca, R.. "Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer". Journal of Clinical Pathology 61 1 (2008): 25-30. http://www.scopus.com/inward/record.url?eid=2-s2.0-38449100410&partnerID=MN8TOARS.
    10.1136/jcp.2006.043679
  162. Kaurah, P.; MacMillan, A.; Boyd, N.; Senz, J.; De Luca, A.; Chun, N.; Suriano, G.; et al. "Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer". Journal of the American Medical Association 297 21 (2007): 2360-2372. http://www.scopus.com/inward/record.url?eid=2-s2.0-34249989159&partnerID=MN8TOARS.
    10.1001/jama.297.21.2360
  163. Preto, A.; Moutinho, C.; Velho, S.; Oliveira, C.; Rebocho, A.P.; Figueiredo, J.; Soares, P.; Lopes, J.M.; Seruca, R.. "A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation". Virchows Archiv 450 6 (2007): 619-626. http://www.scopus.com/inward/record.url?eid=2-s2.0-34250805986&partnerID=MN8TOARS.
    10.1007/s00428-007-0420-9
  164. Corso, G.; Roviello, F.; Paredes, J.; Pedrazzani, C.; Novais, M.; Correia, J.; Marrelli, D.; et al. "Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management". European Journal of Surgical Oncology 33 9 (2007): 1061-1067. http://www.scopus.com/inward/record.url?eid=2-s2.0-35549011087&partnerID=MN8TOARS.
    10.1016/j.ejso.2007.03.001
  165. Masciari, S.; Larsson, N.; Senz, J.; Boyd, N.; Kaurah, P.; Kandel, M.J.; Harris, L.N.; et al. "Germline E-cadherin mutations in familial lobular breast cancer". Journal of Medical Genetics 44 11 (2007): 726-731. http://www.scopus.com/inward/record.url?eid=2-s2.0-36348986039&partnerID=MN8TOARS.
    10.1136/jmg.2007.051268
  166. Oliveira, C.; Velho, S.; Moutinho, C.; Ferreira, A.; Preto, A.; Domingo, E.; Capelinha, A.F.; et al. "KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression". Oncogene 26 1 (2007): 158-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846048042&partnerID=MN8TOARS.
    10.1038/sj.onc.1209758
  167. Svrcek, M.; El-Bchiri, J.; Chalastanis, A.; Capel, E.; Dumont, S.; Buhard, O.; Oliveira, C.; et al. "Specific clinical and biological features characterize inflammatory bowel disease-associated colorectal cancers showing microsatellite instability". Journal of Clinical Oncology 25 27 (2007): 4231-4238. http://www.scopus.com/inward/record.url?eid=2-s2.0-34948868310&partnerID=MN8TOARS.
    10.1200/JCO.2007.10.9744
  168. Oliveira, C.; Seruca, R.; Carneiro, F.. "Genetics, pathology, and clinics of familial gastric cancer". International Journal of Surgical Pathology 14 1 (2006): 21-33. http://www.scopus.com/inward/record.url?eid=2-s2.0-32344433111&partnerID=MN8TOARS.
    10.1177/106689690601400105
  169. Serpa, J.; Mesquita, P.; Mendes, N.; Oliveira, C.; Almeida, R.; Santos-Silva, F.; Reis, C.A.; et al. "Expression of Leain gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation". Cancer Letters 242 2 (2006): 191-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-33749246714&partnerID=MN8TOARS.
    10.1016/j.canlet.2005.11.009
  170. Pereira, P.S.; Teixeira, A.; Pinho, S.; Ferreira, P.; Fernandes, J.; Oliveira, C.; Seruca, R.; Suriano, G.; Casares, F.. "E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia". Human Molecular Genetics 15 10 (2006): 1704-1712. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745184835&partnerID=MN8TOARS.
    10.1093/hmg/ddl093
  171. Frebourg, T.; Oliveira, C.; Hochain, P.; Karam, R.; Manouvrier, S.; Graziadio, C.; Vekemans, M.; et al. "Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer". Journal of Medical Genetics 43 2 (2006): 138-142. http://www.scopus.com/inward/record.url?eid=2-s2.0-32944469779&partnerID=MN8TOARS.
    10.1136/jmg.2005.031385
  172. Velho, S.; Oliveira, C.; Ferreira, A.; Ferreira, A.C.; Suriano, G.; Schwartz Jr., S.; Duval, A.; et al. "The prevalence of PIK3CA mutations in gastric and colon cancer". European Journal of Cancer 41 11 (2005): 1649-1654. http://www.scopus.com/inward/record.url?eid=2-s2.0-22144452507&partnerID=MN8TOARS.
    10.1016/j.ejca.2005.04.022
  173. Oliveira, C.; Velho, S.; Domingo, E.; Preto, A.; Hofstra, R.M.W.; Hamelin, R.; Yamamoto, H.; Seruca, R.; Schwartz Jr., S.. "Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer". Oncogene 24 51 (2005): 7630-7634. http://www.scopus.com/inward/record.url?eid=2-s2.0-27844458489&partnerID=MN8TOARS.
    10.1038/sj.onc.1208906
  174. Oliveira, C.; Moreira, H.; Seruca, R.; De Oliveira, M.C.; Carneiro, F.. "Role of pathology in the identification of hereditary diffuse gastric cancer: Report of a Portuguese family". Virchows Archiv 446 2 (2005): 181-184. http://www.scopus.com/inward/record.url?eid=2-s2.0-15244362093&partnerID=MN8TOARS.
    10.1093/hmg/ddg316
  175. Domingo, E.; Niessen, R.C.; Oliveira, C.; Alhopuro, P.; Moutinho, C.; Espin, E.; Armengol, M.; et al. "BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes". Oncogene 24 24 (2005): 3995-3998. http://www.scopus.com/inward/record.url?eid=2-s2.0-20544437157&partnerID=MN8TOARS.
    10.1038/sj.onc.1208569
  176. Gorringe, K.L.; Chin, S.-F.; Pharoah, P.; Staines, J.M.; Oliveira, C.; Edwards, P.A.W.; Caldas, C.. "Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer". Carcinogenesis 26 5 (2005): 923-930. http://www.scopus.com/inward/record.url?eid=2-s2.0-19844366700&partnerID=MN8TOARS.
    10.1093/carcin/bgi032
  177. Oliveira, C.; Ferreira, P.; Nabais, S.; Campos, L.; Ferreira, A.; Cirnes, L.; Castro Alves, C.; et al. "E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients". European Journal of Cancer 40 12 (2004): 1897-1903. http://www.scopus.com/inward/record.url?eid=2-s2.0-3843061612&partnerID=MN8TOARS.
    10.1016/j.ejca.2004.04.027
  178. Oliveira, C.; Suriano, G.; Ferreira, P.; Canedo, P.; Kaurah, P.; Mateus, R.; Ferreira, A.; et al. "Genetic screening for familial gastric cancer". Hereditary Cancer in Clinical Practice 2 2 (2004): 51-64. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013124211&partnerID=MN8TOARS.
    10.1186/1897-4287-2-2-51
  179. Domingo, E.; Espín, E.; Armengol, M.; Oliveira, C.; Pinto, M.; Duval, A.; Brennetot, C.; et al. "Activated BRAF Targets Proximal Colon Tumors with Mismatch Repair Deficiency and MLH1 Inactivation". Genes Chromosomes and Cancer 39 2 (2004): 138-142. http://www.scopus.com/inward/record.url?eid=2-s2.0-9144271690&partnerID=MN8TOARS.
    10.1002/gcc.10310
  180. Oliveira, C.; Westra, J.L.; Arango, D.; Ollikainen, M.; Domingo, E.; Ferreira, A.; Velho, S.; et al. "Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status". Human Molecular Genetics 13 19 (2004): 2303-2311. http://www.scopus.com/inward/record.url?eid=2-s2.0-5444224121&partnerID=MN8TOARS.
    10.1093/hmg/ddh238
  181. Oliveira, C.; De Bruin, J.; Nabais, S.; Ligtenberg, M.; Moutinho, C.; Nagengast, F.M.; Seruca, R.; Van Krieken, H.; Carneiro, F.. "Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour". Oncogene 23 12 (2004): 2236-2240. http://www.scopus.com/inward/record.url?eid=2-s2.0-1842591223&partnerID=MN8TOARS.
    10.1038/sj.onc.1207335
  182. Carvalho, B.; Pinto, M.; Cirnes, L.; Oliveira, C.; Machado, J.C.; Suriano, G.; Hamelin, R.; Carneiro, F.; Seruca, R.. "Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas". European Journal of Cancer 39 9 (2003): 1222-1227. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037565368&partnerID=MN8TOARS.
    10.1016/S0959-8049(03)00177-1
  183. Suriano, G.; Oliveira, C.; Ferreira, P.; Machado, J.C.; Bordin, M.C.; De Wever, O.; Bruyneel, E.A.; et al. "Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands". Human Molecular Genetics 12 5 (2003): 575-582. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037342636&partnerID=MN8TOARS.
    10.1093/hmg/ddg048
  184. Oliveira, C.; Seruca, R.; Caldas, C.; Oliveira, C; Seruca, R; Caldas, C. "Genetic screening for hereditary diffuse gastric cancer". Expert Review of Molecular Diagnostics 3 2 (2003): 201-215. http://www.scopus.com/inward/record.url?eid=2-s2.0-0012463365&partnerID=MN8TOARS.
    10.1586/14737159.3.2.201
  185. Pinto, M.; Wu, Y.; Suriano, G.; Mensink, R.G.J.; Duval, A.; Oliveira, C.; Carvalho, B.; et al. "MBD4 mutations are rare in gastric carcinomas with microsatellite instability". Cancer Genetics and Cytogenetics 145 2 (2003): 103-107. http://www.scopus.com/inward/record.url?eid=2-s2.0-0043165104&partnerID=MN8TOARS.
    10.1016/S0165-4608(03)00062-1
  186. Brennetot, C.; Duval, A.; Hamelin, R.; Pinto, M.; Oliveira, C.; Seruca, R.; Schwartz Jr., S.. "Frequent Ki-ras mutations in gastric tumors of the MSI phenotype [1]". Gastroenterology 125 4 (2003): 1282-1283. http://www.scopus.com/inward/record.url?eid=2-s2.0-0141483004&partnerID=MN8TOARS.
    10.1016/j.gastro.2003.02.002
  187. Pinto, M.; Oliveira, C.; Cirnes, L.; Machado, J.C.; Ramires, M.; Nogueira, A.; Carneiro, F.; Seruca, R.. "Promoter methylation of TGFß receptor I and mutation of TGFß receptor II are frequent events in MSI sporadic gastric carcinomas". Journal of Pathology 200 1 (2003): 32-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037987704&partnerID=MN8TOARS.
    10.1002/path.1327
  188. Serpa, J.; Almeida, R.; Oliveira, C.; Silva, F.S.; Silva, E.; Reis, C.; Le Pendu, J.; et al. "Lewis enzyme (a1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population". Journal of Human Genetics 48 4 (2003): 183-189. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037908695&partnerID=MN8TOARS.
    10.1007/s10038-003-0007-5
  189. Pharoah, P.D.P.; Oliveira, C.; Machado, J.C.; Keller, G.; Vogelsang, H.; Laux, H.; Becker, K.-F.; et al. "CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancer". International Journal of Cancer 101 2 (2002): 196-197. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037056235&partnerID=MN8TOARS.
    10.1002/ijc.10590
  190. Oliveira, C.; Bordin, M.C.; Grehan, N.; Huntsman, D.; Suriano, G.; Machado, J.C.; Kiviluoto, T.; et al. "Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred". Human Mutation 19 5 (2002): 510-517. http://www.scopus.com/inward/record.url?eid=2-s2.0-18344384564&partnerID=MN8TOARS.
    10.1002/humu.10068
  191. Carvalho, R.; Kayademir, T.; Soares, P.; Canedo, P.; Sousa, S.; Oliveira, C.; Leistenschneider, P.; et al. "Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.". Lab Invest 82 10 (2002): 1319-26. http://www.ncbi.nlm.nih.gov/pubmed/12379766.
    10.1097/01.LAB.0000029205.76632.A8
  192. Caldas, C; Carneiro, F; Lynch, HT; Yokota, J; Wiesner, GL; Powell, SM; Lewis, FR; et al. "Familial gastric cancer: overview and guidelines for management". Journal of Medical Genetics 36 12 (1999): 873-880. http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000084264400001&KeyUID=WOS:000084264400001.
    10.1038/labinvest.3780201
  193. Oliveira, C.; Seruca, R.; Seixas, M.; Sobrinho-Simões, M.; Oliveira, C; Seruca, R; Seixas, M; Sobrinho-Simoes, M. "The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different 'target genes': A study of the TGFß RII, IGFII R, and BAX genes". American Journal of Pathology 153 4 (1998): 1211-1219. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031710793&partnerID=MN8TOARS.
    10.1016/S0002-9440(10)65665-9
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/01/08 "Tumours supressor genes and genetic instability" Lecture on PDMOM/MOM PhD program – Oncobiology course – IPATIMUP
(Porto, Portugal)
2023/12/11 "Discovery of disease mechanisms: Impact for patients, their families and the society" Lecture Molecular Mechanisms of Disease| PhD Program in Health Sciences | Faculty of Medicine of the University of Coimbra
(Coimbra, Portugal)
2023/11/22 "CTNNA1 germline variants: Genotype-phenotype associations" European Reference Network GENTURIS Webinar
(Online)
2023/11/01 "Genotype-phenotype associations and life-time risks in Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer syndrome" NIH seminar Series
(Washington DC, United States)
2023/10/21 "Risco de cancro à nascença: informação, testes genéticos e profilaxia" Conferência: Risco de Doença: Nascer com a espada sobre a cabeça”.FOLIO 2023, CASA JOSÉ SARAMAGO – BIBLIOTECA MUNICIPAL
(Óbidos, Portugal)
2023/10/13 "CDH1 VARIANTS AND PHENOTYPES" CDH1 related hereditary diffuse type gastric cancer: from preventive total gastrectomy to optimal endoscopic surveillance. European Joint Program for Rare Diseases
(Nijmegen, Netherlands)
2023/10/12 "Functional genomics: Tools and models to solve rare disease causes" GROUP LEADER SEMINAR SERIES. i3S CANCER RESEARCH LINE
(Porto, Portugal)
2023/09/29 "Hereditary Gastric Cancer" ESMO PRECEPTORSHIP PROGRAMME on hereditary cancer genetics - Multidisciplinary management, standards of care and future perspectives.
(Paris, France)
2023/09/23 "Variant Classification" Parallel Specialized lectures. 4th Course in Hereditary Cancer Genetics
(Bertinoro, Italy)
2023/09/22 "Hereditary Gastric Cancer" Tumours Syndromes session. 4th Course in Hereditary Cancer Genetics
(Bertinoro, Italy)
2023/09/21 "Basics in Exome analysis" Parallel Specialized lectures. 4th Course in Hereditary Cancer Genetics
(Bertinoro, Italy)
2023/04 "Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increases penetrance of Hereditary Diffuse Gastric Cancer" Solve-RD Final Meeting
(Prague, Czech Republic)
2023/03/04 "DAS GUIDELINES À PRÁTICA CLÍNICA DO DIA A DIA" Meeting One year Together: A new era for BRCAm Ovarian and Breast cancer patients.
(Porto, Portugal)
2023/02/14 "Cancro Hereditário do estômago: Aspetos clínicos e moleculares" Lesson to high School students ESCOLA RODRIGUES DE FREITAS
(Porto, Portugal)
2023/01/05 "Hereditary Gastric Cancer: Clinical and molecular aspects" Lesson Unidade Curricular: ONCOBIOLOGIA I & II. Programa de Doutoramento em Medicina e Oncologia Molecular; Programa de Doutoramento em Biomedicina; Programa de Doutoramento em Patologia e Genética Molecular
(Porto, Portugal)
2022/11/30 "Dos genes aos genomas: o caminho para a descoberta de novas causas de doenças" Panel Translational Research. Fórum Medicina de Precisão em Oncologia.
(Porto, Portugal)
2022/11/17 "Estratégia Nacional para a Medicina Genómica: antecedentes, conceito e iniciativas em curso" Mesa de Medicina Genómica. 19º Congresso Nacional Oncologia.
(Porto, Portugal)
2022/10/20 "Hereditary Gastric Cancer – updates" Hereditary predisposition to cancer Session. II INTERNACIONAL EINSTEIN SIMPOSIUM ON PRECISION MEDICINE
(Online, Brazil)
2022/10/19 "Hereditary Gastric Cancer: Clinical and molecular aspects" Patient Involvement and Ethics – Summer School in Translational Cancer Research 2022. Cancer care Europe.
(Albufeira, Portugal)
2022/10/03 "Phenotypes and multiomics: a likely solution to solve the unsolved in rare diseases" Computational Biology and Bioinformatics series. Institute of Molecular Medicine
(Lisbon, Portugal)
2022/10 "Genomic data and clinical information: the two pillars that sustain genetic diagnosis I & II" Graduation in genetics and genomics in clinics (GGGC). NOVA Medical School| Faculdade de Ciências Médicas Universidade NOVA de Lisboa
(Lisbon, Portugal)
2022/09 "Genotype-Phenotype Correlations in CDH1 and CTNNA1 variant carriers: a tool to understand variant actionability and improve clinical guidelines" 2nd MILAN CANCER MEETING Innovations in prevention, research and care
(Milan, Italy)
2022/09 "Cancer Epigenetics" 11th WORKSHOP ON CANCER RESEARCH: Biological and Molecular basis
(Porto, Portugal)
2022/09 "Hereditary diffuse gastric cancer: Status Quo" CBGM 2022 - 33rd Brazilian Congress of Medical Genetics
(Curitiba, Brazil)
2022/06 "CDH1 LOCUS DISRUPTION: genome-wide functional impacts" Session 5: Biomedical Genetics. II International Meeting of the Portuguese Society of Genetics
(Évora, Portugal)
2022/05 "Cancer Prevention and Early Detection" Encontro Ciência 2022 – Fighting Cancer Portuguese and European Initiatives
(Lisbon, Portugal)
2022/03 "Genotype-Phenotype Associations in CDH1 pathogenic and likely pathogenic variant carrier families" Scientific session: CDH1 & Gastric Cancer Genetics – online.
(Online)
2022/02 "The CDH1 and other familial gastric cancer genotype-phenotype associations: an ERN GENTURIS project" ERN GENTURIS Tumour Predisposition Conference – online.
(Online)
2022/02 "TIPS to Get Your Research Project Funded" LYRIS Course - Online Event.
(Online)
2021/12 "Síndromes ligados ao cancro: o contexto ideal para prevenção" Breast Center Seminar in CHUSJ
(Porto, Portugal)
2021/11 "The Genetics Scientist perspective" - Ethical imperative - the importance of quality on diagnostics and practice in Genetic Medicine. 25th Annual Meeting SPGH
(Online)
2021/10 "Novos Genes Novas Recomendações" - Thematic Session "New Genes New Recommendations" XI National Congress of Senology
(Porto, Portugal)
2021/10 "CTNNA1 database" ERN GENTURIS meeting – online.
2021/10 "Gastric cancer: predisposing factors and clinical biomarkers" III Symposium on Applied Biochemistry in University of Minho. Braga
2021/09 "Cancer Epigenetics" 10th Workshop on Cancer Research: Biological and Molecular basis, i3S
(Porto, Portugal)
2021/04 "Genotypes vs Phenotypes: Solving the unsolved in Hereditary Diffuse Gastric Cancer" Group Leader Seminar at i3S
(Porto, Portugal)
2021/02 "Síndromes associados a cancro: o ponto de encontro da investigação em genética humana e da vida real". Questions & Answers (Q & A) 2nd Edition. Portuguese Society of Genetics.
(Porto, Portugal)
2021/01 "WP5: Bioinformatics tools to explore cell/EVs contents" TRAIN-EV Virtual Meeting
(Online)
2020/05 "Familial Gastric Cancer: hidden layers of a genetically heterogeneous Disease" CI-IPOP/EPOP Scientific meeting - Online
CI-IPOP/EPOP (Porto, Portugal)
2019/12 "Hereditary Diffuse Gastric Cancer: From genes to disease phenotypes" 2019 Seoul International Gastric Cancer Forum
International Gastric Cancer Forum (Seoul, South Korea)
2019/07 "Molecular determinants of gastric cancer: predisposing factors and intra-tumoral heterogeneity" 3rd Annual Meeting CINBIO
Centro De Investigaciones Biomédicas (Vigo, Spain)
2019/06 "European Reference Networks: What is in it for me?". European Human Genetics Conference 2019
European Human Genetics (ESHG) (Gothenburg, Sweden)
2019/06 "Beyond the coding sequence of CDH1: lessons from Hereditary Diffuse Gastric Cancer syndrome". CEDOC Seminar
CHRONIC DISEASES RESEARCH CENTER (Lisboa, Portugal)
2019/06 "Beyond the coding sequence of CDH1: lessons from Hereditary Diffuse Gastric Cancer syndrome". CEDOC Seminar
CHRONIC DISEASES RESEARCH CENTER (Lisboa, Portugal)
2019/03 "CDH1 locus inactivation: phenotypes and novel mechanisms". 2019 IGCLC Hereditary Diffuse Gastric Cancer Consensus Clinical Guidelines Meeting
IGCLC (Wanaka, New Zealand)
2019/01 "Regulation of the CDH1 locus: Intronic sequences command CDH1 expression" VIII Portuguese Meeting: ptRNA 2019
i3S - Instituto de Investigação e Inovação em Saúde (Porto, Portugal)
2018/12 "Gastric Cancer: novel germline predisposing factors and somatic prognostic markers" Integrative Program Seminar Series: Cancer Research Line
(Porto, Portugal)
2018/11 "Panel Discussion: What are ERNs and what is in there for me?" Satellite Meeting-European Reference Networks in Portugal on the 22nd Annual Meeting SPGH
(Porto, Portugal)
2018/09 "Up-date in Hereditary Gastric Cancer" Session: GENETIC FOR LIFE. The new Frontiers in gastric cancer diagnosis and treatment.
(Forli, Italy)
2018/07 "Gastric Cancer: the genetics behind the biology of a lethal disease" Encontro com a Ciência e a Tecnologia em Portugal. Tema - 3 - Saúde de Qualidade – ONCOLOGIA.
(Lisbon, Portugal)
2018/05 "Round Table: A PhD for the XXI century" 1st i3S PhDay
(Porto, Portugal)
2018/05 "Tumor cell invasion and metastasis: Epithelial to mesenchymal transition and cancer cell plasticity" Lecture on VII Workshop on Cancer Research
(Porto, Portugal)
2018/05 "Presentation of the European Reference Network GENTURIS - Genetic tumour risk syndromes: opportunities to improve health care for patients with hereditary cancer syndromes in Europe" Workshop on 3rd ASPIC International Congress
(Lisboa, Portugal)
2018/05 "GEIVEX / Portuguese branch" ISEV2018 Annual Meeting - Meet the National Societies and Outreach Strategies
(Barcelona, Spain)
2018/04 "Hereditary Diffuse Gastric Cancer" Lecture on 2nd Spring Course in Hereditary Cancer Genetics.
(Bertinoro, Italy)
2018/03 "Redefining Germline Mechanisms of Disease" Lecture on GABBA Oncobiology Module
(Porto, Portugal)
2018/02 "Horizontally transferable mechanisms in gastric cancer: modulators of cellular behavior and cancer biomarkers". 1st Meeting on Vesicular Biology
(Coimbra, Portugal)
2018/01 "Genes supressores tumorais e instabilidade genética" Lecture on PDMOM/MOM PhD program – Oncobiology course – IPATIMUP
(Porto, Portugal)
2017/12 "From diseases to causative molecular events: genetic, epigenetic and horizontally transferable mechanisms" Lecture on Molecular Mechanisms of Disease, PhD Program in Health Sciences, FMUC
FMUC (Coimbra, Portugal)
2017/11 Light and Antibodies Fighting Gastric Cancer I3S Distinguished Lectures. I3S Annual Meeting 2017
i3S (Póvoa de Varzim, Portugal)
2017/10 "Genetics and gastric cancer" Session: Which diseases are inherited? UEG United European Gastroenterology Week 2017
UEG (Barcelona, Spain)
2017/07 "Hereditary Gastric Cancer" Lecture on post-graduate course - A Multidisciplinary approach to Hereditary GI Cancers: from Bench to Bedside (ESDO-ESGE-InSIGHT)
ESDO-ESGE-InSIGHT (Florence, Italy)
2017/06 "CDH1 germline noncoding defects: the missing mechanisms in Hereditary Diffuse Gastric Cancer" One Day Symposium with Patrick Tan: Knowns & Unknowns in Gastric Cancer and Other Tumours of the Digestive System
i3S (Porto, Portugal)
2017/05 "Clinical utility of high-throughput genome analysis and impact for patient treatment" First DOCnet Consortium Meeting, Faculty of Medicine of the University of Porto (FMUP)
FMUP (Porto, Portugal)
2017/05 "microRNAs in screening programs of high risk patients/regions: how far are we?" Esophagus and Gastric Cancer Session. Leaping Forward Oncology – International Clinical Congress 2017
International Clinical Congress (Lisbon, Portugal)
2017/05 "microRNAs in screening programs of high risk patients/regions: how far are we?" Esophagus and Gastric Cancer Session. Leaping Forward Oncology – International Clinical Congress 2017
Leaping Forward Oncology (Lisbon, Portugal)
2017/05 "Tumor cell invasion and metastasis: Epithelial to mesenchymal transition and cancer cell plasticity" VII Workshop on Cancer Research
IPATIMUP (Porto, Portugal)
2017/05 "Current challenges in familial gastric cancer" Lecture on Master course - Oncobiologia da Faculdade de Medicina de Lisboa (FMUL) – Módulo de Risco Familiar
FMUL (Lisbon, Portugal)
2017/05 "Oncogenes and Tumor suppressor genes" Invited lecture at ICBAS
ICBAS (Porto, Portugal)
2017/04 "The translational value of germline and somatic mechanisms for diagnosis and anti-cancer therapy in gastric cancer" Integrative Program Seminar Series: Cancer Research Line
i3S (Porto, Portugal)
2017/03 "Molecular determinants of gastric cancer: genotypes, phenotypes and impact in progression and treatment" Seminar at Instituto de Saúde Pública da Universidade do Porto (ISPUP)
ISPUP (Porto, Portugal)
2017/02 "Redefining germline mechanisms of disease" Lecture on GABBA Oncobiology Module
GABBA (Porto, Portugal)
2017/01 "Genes supressores tumorais e instabilidade genética" Lecture on PDMOM/MOM PhD program – Oncobiology course
IPATIMUP (Porto, Portugal)
2016/12 "From disease to causative gene events: an omics approach in gastric cancer" Keynote Lecture XIX National Congress of Biochemistry
SPB (Guimarães, Portugal)
2016/10 "Current challenges in familial gastric cancer" Symposium update – erbliche gastrointestinale karzinomerkrankungen Munich
(Munich, Germany)
2016/08 "Molecular determinants of gastric cancer: genotypes, phenotypes and impact in progression and treatment" Seminar series National Cancer Center Research Institute
National Cancer Center Research Institute (Tokyo, Japan)
2016/07 "Cancro gástrico esporádico e familiar: aspectos genéticos" Congresso da EUROPACOLON Portugal em Oncologia Digestiva
Fundação Cupertino Miranda (Porto, Portugal)
2016/06 "From single genes to full genomes, from single mechanisms to complex pathways" iBiMED International Advanced Training School. Omics in Biomedicine: linking genes and metabolites
iBiMED (Aveiro, Portugal)
2016/05 "Tumor cell invasion and metastasis: Epithelial to mesenchymal transition and cancer cell plasticity" VI Workshop on Cancer Research
IPATIMUP (Porto, Portugal)
2016/04 "Epigenetic mechanisms of gene expression regulation in gastric cancer" ICVS Course Epigenetics - from mechanisms to disease
ICVS (Braga, Portugal)
2016/04 "From single causing genetic mutations to multiple modifying mutations in cancer- the journey of a life-time" III Jornadas da Bioquímica "Bioquímicos pelo Mundo”
(Porto, Portugal)
2016/04 "Hereditary Diffuse Gastric Cancer" 1st Spring Course in Hereditary Cancer Genetics
(Bertinoro, Italy)
2016/03 "Effect of cancer cell-derived extracellular vesicles over normal cells from the microenvironment" Spring Meeting of the Cost Action European Network on Microvesicles and Exosomes in Health and Disease
(Ioannina, Greece)
2015/10 "Molecular determinants of cancer: genotypes and phenotypes" iBiMED Seminar Series
iBiMED (Aveiro, Portugal)
2015/07 "From single causing genetic mutations to multiple modifying mutations in cancer" INEB Summer Science Club: Integrating Competences
INEB (Porto, Portugal)
2015/06 "GASTRIC CANCER THERAPY, THE ERA OF FUNCTIONAL GENOMICS" Post-graduated course “Cancer therapy: from basic research to clinic“
University of Minho (Braga, Portugal)
2015/05 "Genomics and Transcriptomics in cancer research" V Workshop on Cancer Research – Biological and molecular basis
IPATIMUP/ICBAS (Porto, Portugal)
2015/04 "Genómica e Bioinformática: O que o clínico deve saber" XXXVI Congresso Português de Cardiologia
(Albufeira, Portugal)
2015/02 "The genomics and bioinformatics era: does it help understanding better sporadic and hereditary cancer?" Research Seminar, IPO
Instituto Português de Oncologia - Lisboa (Lisbon, Portugal)
2015/01 "Using NGS to uncover structural and regulatory variation in gastric cancer" COIMBRA GENOMICS Annual MEETING, CURIA
(Coimbra, Portugal)
2014/11 "Germline and somatic determinants of gastric cancer: Next Generation Sequencing and Functional Genomics" Ministry of Health - MD Anderson Cancer Center Joint Conference on Gastric and Hereditary Cancer
Lisbon Academic Medical Center (Lisbon, Portugal)
2014/11 "Through the looking glass: the reversion of EMT" 1st International Congress ASPIC – Associação Portuguesa de Investigação em Cancro
ASPIC (Lisbon, Portugal)
2014/10 "Hereditary GI cancer: New genes, old diseases" UEG – United European Gastroenterology Week
UEG (Vienna, Austria)
2014/10 "The role and cargo of EVs in epithelial-mesenchymal-epithelial transitions and gastric cancer progression" II GEIVEX SYMPOSIUM: Extracellular vesicles, from the bench to the clinics. Satellite Meeting of the Portuguese Groups on Extracellular Vesicles
GEIVEX (Taragona, Spain)
2014/10 "The role and cargo of EVs in epithelial-mesenchymal-epithelial transitions and gastric cancer progression" Autumn Meeting of the Cost action European Network on Microvesicles and Exosomes in Health and Disease
(Palermo, Italy)
2014/07 "Can you use next generation sequencing data from tumours to rationally select targeted therapy approaches?" BioP5med Unworkshop, IGC - Oeiras
IGC (Lisbon, Portugal)
2014/05 "Metastable phenotypes" ONCOBIOLOGY - genes and tumoral microenvironment Seminar Series
Medical Sciences Faculty - NOVA University (Lisbon, Portugal)
2014/05 "Genomics and Transcriptomics in cancer research" IV Workshop on Cancer Research
IPATIMUP (Porto, Portugal)
2014/04 "Next Generation Sequencing (NGS): Principles and clinical applications" 6th Scientific Meeting of the Portuguese Society of Clinical Chemistry and Laboratorial Medicine
Portuguese Society of Clinical Chemistry and Laboratorial Medicine (Coimbra, Portugal)
2014/03 "Germline and somatic determinants in gastric cancer: a focus on E-cadherin" Oncology Meetings: Gastric Cancer - State of Art
University of Minho (Braga, Portugal)
2013/12 "Using NGS and in Vitro Models to Understand Structural and Regulatory Variation in Gastric Cancer" Bio-IT World and Cambridge Healthtech Institute’s Second Annual, Clinical Genomics and Genome Informatics Europe, Deciphering Disease through Sequencing Data
Bio-IT World and Cambridge Healthtech Institute (Lisbon, Portugal)
2013/11 "Using molecular stratification and NGS to Understand Structural and Regulatory Variation in Gastric Cancer" 17th SPGH Annual Meeting
SPGH (Coimbra, Portugal)
2013/11 "Modulation of cell-cell adhesion in cancer and epithelial-mesenchymal-epithelial transition?" IMM Monday lectures
IMM (Lisbon, Portugal)
2013/10 "Metastatic pathways in gastric cancer: is there a role of Extracellular Vesicles?" 2nd Meeting COST Action_BM1202 ME-HAD
Semmelweis University (Budapest, Hungary)
2013/10 "Germline and somatic determinants in gastric cancer - impact in diagnosis, prognosis and treatment" Monday Seminar Medical Faculty University of Porto
FMUP (Porto, Portugal)
2013/10 "Modulation of E-cadherin expression and function in gastric cancer - clinical and molecular features" 19TH GI CANCER FORUM - The Martin Cohen Lecture Theatre, CRUK CRI - Li Ka Shing Centre
(Cambridge, United Kingdom)
2013/07 "Molecular mechanisms modulating the function of the invasion suppressor protein E-cadherin" Institut Curie, Université Paris-SUD
(Paris, France)
2013/06 "HDGC: Updated guidelines for clinical management" IGCC 2013, 10th International Gastric Cancer Congress
IGCC (Verona, Italy)
2013/05 "Cancer Metastization: Examples from the wet lab" III Workshop on Cancer Research
IPATIMUP (Porto, Portugal)
2013/05 "Genetics of hereditary diffuse gastric cancer - HDGC" Funderburg Symposium - “Current Approach to Hereditary Diffuse Gastric Cancer (HDGC) syndrome”. DDW 2013 Digestive Disease Week Orlando
DDW (Orlando, United States)
2013/01 "From disease to mechanisms: old and new stories about E-cadherin" Instituto Mexicano de Seguro Social Guadalajara Mexico
IMMS (Guadalajara, Mexico)
2013/01 "Dissecting the role of cadherins with OMICS technologies" Course: “New frontiers of OMICs in Medicine - from the lab to a clinical setting”
IBILI (Coimbra, Portugal)
2012/09 "Dissecting the role of cadherins with genome-wide technologies" User Meeting Genómica
IBILI (Coimbra, Portugal)
2012/06 "Novel molecular mechanisms modulating the function of the invasion suppressor protein E-cadherin" 2nd IBEC-INEB Advanced Summer School
IBEC Barcelona (Barcelona, Spain)
2012/04 "From disease to mechanisms: old and new stories about E-cadherin" CDR Saint-Antoine
(Paris, France)
2012/03 "Epigenetic Changes in Cancer and Epithelial to Mesenchymal Transitions" Mini-symposium on Epigenetics and Cancer
IBMC (Porto, Portugal)
2011/05 "E-cadherin the sticky component of epithelial tissues: old gene new stories" CEDOC
(Lisbon, Portugal)
2011/05 "Tumor cell invasion and metastasis" I Workshop on Cancer Research: biological and molecular basis
(Porto, Portugal)
2011/05 "Regulation of E-cadherin expression and function in cancer" BIOCANT
(Coimbra, Portugal)
2010/09 "Regulatory RNA molecules modulating the function of E-cadherin" Mini-Symposium on “Mechanisms of Gene Expression
IPATIMUP (Porto, Portugal)
2010/04 "Functions of non-coding RNAs in gene regulation and disease" ICBAS
(Porto, Portugal)
2010/04 "Coding and non-coding RNAs controlling E-cadherin expression and function" “RNA world: not so small” Life Technologies/Applied Biosystems Symposium
(Porto, Portugal)
2010/03 "E-cadherin and Hereditary Diffuse Gastric Cancer (HDGC)" I Meeting on Biomedical Sciences
(Aveiro, Portugal)
2009/11 "Functions of non-coding RNAs in gene regulation and disease" Annual Meeting Portuguese Society of Human Genetics
(Porto, Portugal)
2009/06 "Nanoparticles as a vehicle to decrease cancer risk" Symposium 20 years of Biomagical Engineering
(Braga, Portugal)
2009/05 "E-cadherin expression regulation in Cancer: new targets of regulation in the E-cadherin locus” SINAL 2009 - 3rd Meeting on Signal Transduction
(Aveiro, Portugal)
2008/12 "Modulating the expression of E-cadherin (CDH1) in Hereditary Diffuse Gastric Cancer" IGC
(Lisbon, Portugal)
2008/11 "Modulating the expression of E-cadherin (CDH1) in Hereditary Diffuse Gastric Cancer" Annual Meeting Portuguese Society of Human Genetics
SPGH (Lisbon, Portugal)
2008/01 "Gastric cancer" Seminars in Biopathology. Faculty of Medicine
FMUP (Porto, Portugal)
2007/10 "Hereditary Diffuse Gastric Cancer (HDGC): The model of E-Cadherin (CDH1)" VuMC
(Amsterdam, Netherlands)
2007/03 "BRAF and KRAS activating mutations in colorectal carcinogenesis" SINAL – 1st National Meeting on Signal Transduction
SINAL (Lisbon, Portugal)
2004/05 "KRAS and BRAF in gastrointestinal neoplasia" INSERM
(Paris, France)
2004/05 "Distinct patterns of KRAS mutations in colorectal carcinomas according to germline Mismatch Repair defects and hMLH1 methylation status" XIII Porto Cancer Meeting: Mismatch repair genes, Microsatellite Instability, and Cancer
(Porto, Portugal)
2004/04 "KRAS and BRAF in MSI gastric and colorectal carcinomas" 10th Multidisciplinary Meeting in Oncology
(Lisbon, Portugal)
2002/06 "Genetic factors of hereditary gastric cancer" Meeting on psycho-social and ethical aspects of genetic testing: neurological diseases and hereditary cancer
(Porto, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2019/10 - Current The Primary Genetic Cause and Beyond: Life-Time Risk and Phenotype Modifiers in HDGC
Supervisor of Ana Rita Matos
 Doutoramento (PhD)
BiotechHealth Programme, Portugal
2019/01 - Current INHERITED PREDISPOSITION TO GASTRIC CANCER: NOVEL SUSCEPTIBILITY GENES AND A MINIMALLY INVASIVE SCREENING STRATEGY IN GERMLINE MUTATION CARRIERS
Supervisor of Joana Guerra
 Doutoramento (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019 - Current Irene Gullo, Molecular Pathologist interested in exploring the molecular and histolopathological mechanisms underlying the transition between indolent and aggressive phenotypes in CDH1-associated hereditary diffuse gastric cancers. i3S/ULS São João/FMUP, Porto, PT
Supervisor
 Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2018/10 - Current "SOLVING THE UNSOLVED RARE DISEASES: HEREDITARY DIFFUSE GASTRIC CANCER"
Supervisor of José Pelaez
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/09 - Current "DEVELOPMENT OF AN INTEGRATED KNOWLEDGE BASE FOR GASTRIC CANCER"
Co-supervisor of Rúben Rodrigues
 Doutoramento (PhD)
Universidade do Minho, Portugal
2022 - 2027 João Neto (2022-2027), Junior Researcher using CRISPR screens to uncover new mechanisms of therapy resistance in HER2-positive gastric cancers. Salary funded by a CEEC-FCT individual position. i3S/ The Netherlands Cancer Institute, Porto/Netherlands, PT/NL.
Supervisor
 Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2023 - 2025 Ricardo Amorim (2023-2025), Junior Researcher working in the establishment of clinical pathways of care from patients with Rare tumour risk Syndromes and associated care expenditure. Salary funded by the Horizon Europe PREVENTABLE project. i3S, Porto, PT.
Supervisor
 Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2023 - 2025 Celina São José (2023-2025), Post-doc fellow addressing the identification of germline mechanisms underlying the missing heritability in Hereditary Gastric Cancer. Salary funded by the Horizon Europe PREVENTABLE project. i3S, Porto, PT.
Supervisor
 Post-doc
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2023 - 2025 Sara Pereira (2023-2025), Project Manager and Researcher interested in Cost-effectiveness analysis for care provided to patients with Rare Tumour Risk Syndromes. Salary funded by the Horizon Europe PREVENTABLE project. i3S, Porto, PT.
Supervisor of Sara Pereira
 EU Project Manager
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2022 - 2025 Daniel Ferreira (2022-2025), Junior Researcher working in the development of organ-on-chip platforms to study diffuse gastric cancer initiation and early cancer biomarkers. Salary funded by the Horizon Europe PREVENTABLE project. i3S, Porto, PT.
Supervisor
 Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2021 - 2025 "DEVELOPMENT OF AN ALGORITHM FOR CLASSIFICATION OF VARIANTS OF UNKNOWN SIGNIFICANCE (VUS) USING A COMBINATION OF IN SILICO, IN VITRO AND IN VIVO STUDY MODELS"
Supervisor of Silvana Sousa
Universidade do Porto Faculdade de Medicina, Portugal
2021 - 2025 "BIOPREDICTOR: A TOOL TO PREDICT THE OUTCOME OF MOLECULAR ALTERATIONS"
Supervisor of Marta Ferreira
Universidade do Porto Faculdade de Ciências, Portugal
2020/01 - 2024 "Breaking Barriers and Perceptions: A Path Towards the Increase of Health Professionals Research Engagement"
Co-supervisor of Liliana Sousa
 Doutoramento (PhD)
Universidade do Minho, Portugal
2018/10 - 2023/07 "UNVEIL CDH1 REGULATORY NETWORK, BEYOND CODING MUTATIONS IN HDGC"
Supervisor of Celina São José
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2022 - 2023 "DEVELOPMENT OF METHODS AND PIPELINES FOR NGS DATA ANALYSIS"
Supervisor of Inês Marques
Universidade do Porto Faculdade de Ciências, Portugal
2017/11 - 2022/12 "ADVANCING CANCER RESEARCH: FROM BASIC KNOWLEDGE TO APPLICATION"
Supervisor of Ana André
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2018/12/01 - 2022/02 TRANSLATION ERRORS: A NEW INSTIGATOR OF GENOMIC INSTABILITY IN CANCER
Co-supervisor of Mafalda Santos
Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2021 - 2022 "THE IMPACT OF NONSENSE MEDIATED DECAY ON CTNNA1 VARIANTS IN TUMORIGENESIS AND DIFFERENTIATION"
Supervisor of André Oliveira
Universidade do Porto Faculdade de Engenharia, Portugal
2019/01/01 - 2022 "SOLVING THE 3D CHROMATIN STRUCTURE OF CDH1 LOCUS TO IDENTIFY DISEASE-ASSOCIATED MECHANISMS"
Supervisor of Gabriela Almeida
 Junior Researcher
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2014/07/01 - 2021/12/14 "A TISSUE ENGINEERING APPROACH TO BUILDING A STOMACH-ON-A-CHIP"
Co-supervisor of Daniel Ferreira
 Doutoramento (PhD)
Instituto Nacional de Engenharia Biomédica, Portugal
2017/12 - 2021/10 "STUDY OF CONTROL OF PROTEIN ABUNDANCE USING MULTI-OMICS DATA FROM CANCER SAMPLES”
Co-supervisor of Abel Sousa
 Doutoramento (PhD)
European Bioinformatics Institute, United Kingdom
2017/10 - 2021/04 "LABORATÓRIO NACIONAL DE SEQUENCIAÇÃO E ANÁLISE DE GENOMAS"
Supervisor of Marta Ferreira
 Research Technician (Ref: POCI-01-0145-FEDER-02218) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2017/01 - 2020/09 "DECONSTRUCTING GASTRIC CANCER COLONIZATION: THE INTERPLAY BETWEEN IMMUNE CELLS, GASTRIC CANCER CELLS AND EXTRACELLULAR VESICLES"
Supervisor of Sara Rocha
 Doutoramento (PhD)
BiotechHealth Programme, Portugal
2019/02 - 2020/07 "TACKLING CANCER STEM CELLS: A CHALLENGE AND AN OPPORTUNITY TO ADVANCE IN ANTI-CANCER THERAPY"
Supervisor of Ana Rita Monteiro
 Research Fellowship – MSc (Ref: POCI-01-0145-FEDER-016390) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2018/02 - 2020 "TISSUE ENGINEERED 3D MODELS OF GASTRIC WALL FOR PERMEABILITY STUDIES OF DRUG LOADED NANOPARTICLES"
Co-supervisor of Tiago Santos
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2015/12 - 2020 "UNVEILING THE CROSSTALK BETWEEN E-CADHERIN AND CD44-SPLICE VARIANTS AS A NOVEL STRATEGY TO IMPROVE DRUG SENSITIVITY IN GASTRIC CANCER"
Supervisor of Carla Pereira
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2013/01/01 - 2019/09/06 "BIOENGINEERING 3D MODELS TO DECONSTRUCT THE ROLE OF EXTRACELLULAR MATRIX MICROENVIRONMENT IN GASTRIC CANCER"
Co-supervisor of Bianca Lourenço
 Doutoramento (PhD)
Instituto Nacional de Engenharia Biomédica, Portugal
2019/01 - 2019/09 3DEMT - UMA PLATAFORMA DE MICROARRAYS EM 3D PARA A ANÁLISE DE ALTO RENDIMENTO DO PAPEL DA MATRIZ EXTRACELULAR NAS TRANSIÇÕES EPITELIAL-MESENQUIMAL EM CANCRO
Supervisor of Ana Rita Matos
 Research Fellowship MSc (Ref: PTDC/BBB-ECT/2518/2014) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2018/07 - 2019/09 "ADVANCING CANCER RESEARCH: FROM BASIC KNOWLEDGE TO APPLICATION"
Supervisor of Liliana Sousa
 Research Fellowship MSc (Ref: NORTE-01-0145-FEDER-000029) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2018/07 - 2019/08 "3DEMT - UMA PLATAFORMA DE MICROARRAYS EM 3D PARA A ANÁLISE DE ALTO RENDIMENTO DO PAPEL DA MATRIZ EXTRACELULAR NAS TRANSIÇÕES EPITELIAL-MESENQUIMAL EM CANCRO"
Supervisor of Sara Teles
 Research Fellowship – BI-L (Ref: PTDC/BBB-ECT/2518/2014) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2019/01 - 2019/07 "IntCDH1 - THE INTRONIC REGULATION OF THE CDH1 GENE"
Co-supervisor of Marta Moreno
 Research Fellowship – MSc (Ref: IntCDH1) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2013/09/01 - 2019/03/11 "MORPHOLOGICAL AND IMMUNOPHENOTYPIC HETEROGENEITY IN GASTRIC CANCER"
Co-supervisor of Irene Gullo
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2018 - 2019 "BIOMARKERS IN GASTRIC CANCER"
Co-supervisor of Silvana Sousa
 Mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/08/01 - 2018/12/31 "CIRCULATING EXOSOMES: A TOOL TO FOLLOW GASTRIC TUMOUR DYNAMICS AND THERAPY RESPONSE"
Supervisor of Joana Carvalho
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2016/01/01 - 2018/12/31 "EMT/MET IN GASTRIC CANCER: USING NEXT GENERATION SEQUENCING DATA TO UNCOVER NOVEL THERAPEUTIC TARGETS"
Supervisor of Patricia Oliveira
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2014/03/01 - 2018/12/31 "DISSECTING THE 3D CHROMATIN ARCHITECTURE OF THE CDH1 LOCUS"
Supervisor of Anabela Ferro
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2014/01/01 - 2018/12/31 "IMPROVING GASTRIC CANCER PATIENT STRATIFICATION TOWARDS PERSONALISED THERAPY"
Supervisor of Gabriela Almeida
 Research Associate with an iFCT contract for 5 years (Project Ref. iFCT2013/00615)
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2017/10 - 2018/12 "MAPPING GENETIC AND PHENOTYPIC HETEROGENEITY IN HER2 POSITIVE CANCERS TO ANTICIPATE AND COUNTERACT RESISTANCE PHENOTYPES"
Supervisor of Barbara Mesquita
 Research Fellowship – MSc (Ref: NORTE-01-0145-FEDER-000029) (Other)
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2016/04/01 - 2018/11/30 "ARTIFICIAL EXTRACELLULAR MATRIX-LIKE MATRICES AS 3D IN VITRO MODELS TO INVESTIGATE THE ROLE OF THE MICROENVIRONMENT IN CANCER METASTISATION"
Co-supervisor of Silvia Bidarra
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2014/01/01 - 2018/07/11 "INNOVATIVE COLORECTAL CANCER DIAGNOSIS AND TREATMENT WITH ENGINEERED NANOPARTICLES"
Co-supervisor of Patrick Kennedy
Doutoramento (PhD)
Instituto Nacional de Engenharia Biomédica, Portugal
2013/02/01 - 2018/02/16 "UNRAVELLING THE ROLES OF STATISTICAL PROTEOMES IN HUMAN CANCER"
Co-supervisor of Mafalda Santos
 Doutoramento (PhD)
Universidade de Aveiro, Portugal
2016 - 2018 "CLINICAL AND FUNCTIONAL IMPACT OF A CDH1 GENE MUTATION: FROM THE DEFINITION OF A COMMON ANCESTOR TO THE FUNCTIONAL CHARACTERIZATION OF A CAUSATIVE MUTATION"
Supervisor of Rafaela Silva
 Mestrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2016 - 2018 "DISCLOSING HYPOMETHYLATION AS AN ONCOGENE ACTIVATION MECHANISM"
Supervisor of Sara Teles
 Mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2018 "CDH1 GENOMIC BLUEPRINT: THE ROLE OF ITS CIS-REGULATORY ELEMENTS"
Supervisor of Ana Rita Matos
 Mestrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01/02 - 2017/03/27 "UNRAVELLING THE CELLULAR NETWORKS THAT REGULATE PROTEOTOXIC STRESS"
Co-supervisor of Ana Sofia Varanda
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2015 - 2017 "THE GERMLINE AND SOMATIC LANDSCAPE OF FAMILIAL INTESTINAL GASTRIC CANCER: SEARCH FOR A CAUSE"
Supervisor of Celina São José
 Mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/01/01 - 2016/12/31 "CDH1 EXPRESSION REGULATION: AN ALTERNATIVE MOLECULAR CAUSE FOR HEREDITARY DIFFUSE GASTRIC CANCER"
Supervisor of Hugo Pinheiro
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2012/01/01 - 2016/12/31 "ADHESION, DIFFERENTIATION AND INVASION: DIFFERENT PROCESSES, COMMON CADHERIN PLAYERS"
Co-supervisor of Ana Sofia Ribeiro
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2013/03/01 - 2016/07/31 "STUDY OF SECRETED CELL VESICLES DURING EPITHELIAL-MESENCHYMAL-EPITHELIAL TRANSITIONS AND THEIR ROLE IN THE CANCER METASTATIC PROCESS"
Supervisor of Joana Carvalho
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2014 - 2016 "HEREDITARY DIFFUSE GASTRIC CANCER BEYOND CDH1 CODING MUTATIONS"
Supervisor of Hugo Pinheiro
 Mestrado (Master)
Universidade do Minho Escola de Medicina, Portugal
2014 - 2016 "CHARACTERIZATION OF AN E-CADHERIN-RELATED COMMON ANCESTOR IN HEREDITARY DIFFUSE GASTRIC CANCER FAMILIES FROM THE NORTHERN PORTUGAL"
Supervisor of Ana Aguiar
 Mestrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2014 - 2016 "CDH1 REGULATORY VARIANTS AND HEREDITARY DIFFUSE GASTRIC CANCER"
Supervisor of Ana Sofia Valente
 Mestrado (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2013/01/31 - 2015/12/31 "ALL TOGETHER NOW: COMBINED INFLUENCE OF E-CADHERIN MODULATORS IN EPITHELIAL-MESENCHYMAL-EPITHELIAL TRANSITIONS AND CANCER PROGRESSION"
Supervisor of Patricia Oliveira
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2013 - 2015 "KRAS MUTATIONS IN MICROSATELLITE INSTABLE GASTRIC TUMOURS: IMPACT OF TARGETED TREATMENT AND INTRATUMOURAL HETEROGENEITY"
Supervisor of Pedro Queirós
 Mestrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01/01 - 2014/12/31 "CDH1 LOCUS, THE NEXT JEKYLL AND HYDE IN CANCER?"
Supervisor of Hugo Pinheiro
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2012 - 2014 "DIES1 GENE EXPRESSION AND REGULATION IN GASTRIC CANCER"
Supervisor of Inês Reis
 Mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013/04/01 - 2013/12/31 "TARGETING CHEMOTHERAPY-INDUCED EMT AND CANCER STEM CELLS FOR OVERCOMING TUMOUR DRUG RESISTANCE"
Supervisor of Gabriela Almeida
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2011/01/09 - 2013/03/31 "NEW E-CADHERIN RNAS: THE DARK SIDE OF A TUMOUR SUPPRESSOR GENE"
Supervisor of Denisa Mateus
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2009/02/01 - 2013/03/18 "SUPPRESSOR-TRNAS AS THERAPEUTIC TOOLS FOR CANCER ASSOCIATED SYNDROMES: HDGC AS A MODEL SYSTEM"
Supervisor of Renata Bordeira-Carriço
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2010/01/01 - 2012/12/31 "FUNCTIONAL GENOMICS OF RIBOSOME INFIDELITY PHENOTYPES ASSOCIATED TO HUMAN DISEASES"
Supervisor of Patricia Pereira
 Post-Doctoral
Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2012/01/01 - 2012/12/07 "THE INVOLVEMENT OF MICRORNAS IN GASTRIC CANCER"
Supervisor of Joana Carvalho
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2010 - 2012 "EXPRESSION ANALYSIS OF MICRORNAS TARGETING ADHESION COMPLEX MOLECULES IN GASTRIC CANCER"
Supervisor of Pedro Freitas
 Mestrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2010 - 2012 "AN IN VITRO MODEL OF EMT/MET USING HUMAN NEAR-NORMAL AND CANCER-DERIVED BREAST CELL LINES"
Supervisor of Mafalda Azevedo
 Mestrado (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008 - 2011/12/22 "E-CADHERIN: NEW REGULATORY MECHANISMS IN CANCER"
Supervisor of Hugo Pinheiro
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2007/01/01 - 2010/12/31 "IDENTIFICATION OF NOVEL CIS-REGULATORY ELEMENTS IN THE CADHERIN SUPERFAMILY AND CHARACTERIZATION OF THEIR ROLE IN CANCER-RELATED PROCESSES"
Supervisor of Patricia Oliveira
 Doutoramento (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2006/01/01 - 2010/05/31 "THE ROLE OF BRAF AND KRAS ACTIVATING MUTATIONS IN DEFICIENT AND PROFICIENT MMR COLORECTAL CARCINOMAS"
Co-supervisor of Sérgia Velho
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2006/01/01 - 2010/04/13 "EPIGENETIC, GENETIC AND FUNCTIONAL ANALYSES OF MICRORNA-MACHINERY IN HUMAN CANCER"
Co-supervisor of Sónia Melo
 Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2005/01/01 - 2008/12/02 "THE ROLE OF NONSENSE-MEDIATED MRNA DECAY (NMD) IN THE REGULATION OF CDH1 GENE EXPRESSION AND CANCER DEVELOPMENT"
Supervisor of Rachid Karam
Doutoramento (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2005 - 2007 "E-CADHERIN SILENCING: MORE THAN INACTIVATING MUTATIONS"
Supervisor of Hugo Pinheiro
 Mestrado (Master)
Universidade do Minho, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2024 - Current Organizer and Chair if the Scientific Program Committee of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting 2024, Porto, Portugal. (2024/06 - 2024/06) Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2023 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics 2023, Lisbon, Portugal. (2023/11 - 2023/11) Sociedade Portuguesa de Genética Humana, Portugal
2022 - Current Organizer of the Workshop - European Reference Networks - More than just a wish? in the European Human Genetics Conference (ESHG) 2022, Vienna, Austria. (2022/06 - 2022/06) European Society of Human Genetics, Austria
2022 - Current Organizer and Scientific Program Committee Member of the European Human Genetics Hybrid Conference ESHG 2022, Vienna, Austria. (2022/06 - 2022/06) European Society of Human Genetics, Austria
2022 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics 2022, Coimbra, Portugal. (2022/11 - 2022/11) Sociedade Portuguesa de Genética Humana, Portugal
2021/11 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics 2021, Porto, Portugal. (2021) Sociedade Portuguesa de Genética Humana, Portugal
2021/08 - Current Organizer and Scientific Program Committee Member of the European Human Genetics Virtual Conference ESHG 2021. (2021) European Society of Human Genetics, Austria
2020/11 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics 2020, Porto, Portugal. (2020) Sociedade Portuguesa de Genética Humana, Portugal
2020/06 - Current Organizer of the Workshop ¿W06 - European Reference Networks "What is in it for me?". European Human Genetics Virtual Conference ESHG 2020.2 - Live in Your Living Room. (2020) European Society of Human Genetics, Austria
2020/06 - Current Organizer and Scientific Program Committee Member of the European Human Genetics Virtual Conference ESHG 2020.2 - Live in Your Living Room. (2020) European Society of Human Genetics, Austria
2019/11 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics 2019, Porto, Portugal. (2019/11 - 2019/11) Sociedade Portuguesa de Genética Humana, Portugal
2016/04 - Current Co-Organizer of the “Spring Course in Hereditary Cancer Genetics”. Bertinoro, Italy. (2016/04)
Other (Co-organisor)
 European Society of Human Genetics, Austria
2010/11 - Current Organizer and Chair of the Scientific Program Committee of the Portuguese Society of Human Genetics (2010)
Congress (Member of the Scientific Committee)
 Sociedade Portuguesa de Genética Humana: SPGH, Portugal
2010/06 - Current Organizer and Scientific Program Committee Member of the European Human Genetics Conference (2010/06)
Congress (Member of the Scientific Committee)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2023 - 2023 Organizer and Scientific Program Committee Member of the European Human Genetics Hybrid Conference ESHG 2023, Glasgow, Scotland. (2023/06) European Society of Human Genetics, Austria
2019/11 - 2019/11 Organizer of the Workshop ¿Genetic and Oncology: building bridges. 16th National Congress of Oncology 2019 (2019/11 - 2019/11)
Workshop
 Sociedade Portuguesa de Oncologia, Portugal
2019/06 - 2019/06 Organizer of the Workshop “European Reference Networks – What is in it for me?”. European Human Genetics Conference (ESHG) 2019. Gothenburg, Sweden (2019/06 - 2019/06)
Workshop (Co-organisor)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2018/11 - 2018/11 Organizer of the Workshop: “What are ERNs and what is in there for me?”. Satellite Meeting-European Reference Networks in Portugal on the 22nd Annual Meeting SPGH. Porto, Portugal. (2018/11 - 2018/11)
Workshop (Co-organisor)
 Sociedade Portuguesa de Genética Humana: SPGH, Portugal
2018/05 - 2018/05 Organizer of the workshop “Presentation of the European Reference Network GENTURIS - Genetic tumour risk syndromes: opportunities to improve health care for patients with hereditary cancer syndromes in Europe”. 3rd ASPIC International Congress, Lisbon, Portugal. (2018/05 - 2018/05)
Workshop (Co-organisor)
 Associação Portuguesa de Investigação em Cancro, Portugal

Sociedade Portuguesa de Oncologia, Portugal
2014/10 - 2014/10 Chair of the Session “Gastric cancer: New insights into pathogenesis and management”. UEG – United European Gastroenterology Week, Vienna Austria (2014/10 - 2014/10)
Seminar (Other)
 United European Gastroenterology, Austria
2014/10 - 2014/10 Chair of the Session: Mechanisms underlying the development of GI cancer¿. UEG ¿ United European Gastroenterology Week, Vienna Austria (2014/10 - 2014/10)
Seminar (Other)
 United European Gastroenterology, Austria
2014/10 - 2014/10 Chair of the Session “Clinical perspectives on gastric malignant tumours”. UEG – United European Gastroenterology Week, Vienna Austria (2014/10 - 2014/10)
Seminar (Other)
 United European Gastroenterology, Austria

Sociedade Portuguesa de Oncologia, Portugal
2011/05 - 2011/05 Chair of the “Cancer Genetics” session, The European Human Genetics Conference 2011. Amsterdam, The Netherlands. (2011/05 - 2011/05)
Seminar (Other)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2011/05 - 2011/05 Chair of the "Cancer Genomes" session, The European Human Genetics Conference 2011. Amsterdam, The Netherlands. (2011/05 - 2011/05)
Seminar (Other)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2010/09 - 2010/09 Organizer of the RNA Symposium- 17th National Congress of Biochemistry. Porto, Portugal. (2010/09 - 2010/09)
Symposium (Member of the Organising Committee)
 Sociedade Portuguesa de Oncologia, Portugal
2010/06 - 2010/06 Chair of the “Cancer Genetics” session, The European Human Genetics Conference 2010. Gothenburg, Sweden. (2010/06 - 2010/06)
Seminar (Other)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2010/06 - 2010/06 Chair of the “Long Distance Regulation session”, The European Human Genetics Conference 2010. Gothenburg, Sweden. (2010/06 - 2010/06)
Seminar (Other)
 European Society of Human Genetics, Austria

Sociedade Portuguesa de Oncologia, Portugal
2010/05 - 2010/05 Chair of the SINAL 2010 – 4th National Meeting on Signal Transduction. Univ. of Algarve; Portugal. (2010/05 - 2010/05)
Meeting (Other)
 Universidade do Algarve, Portugal
2009/05 - 2009/05 Chair of the SINAL 2009 - 3nd National Meeting on Signal Transduction. Univ. of Aveiro, Portugal. (2009/05 - 2009/05)
Meeting (Other)
 Universidade de Aveiro, Portugal
2008/05 - 2008/05 Organizer of the SINAL 2008 – 2nd National Meeting on Signal Transduction. Institute for Molecular and Cell Biology (IBMC), Porto, Portugal. (2008/05 - 2008/05)
Meeting (Member of the Organising Committee)
 Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
2004/05 - 2004/05 Organizer of the XIII Edition Porto Cancer Meeting "Mismatch repair genes, Microsatellite instability, and Cancer". IPATIMUP; Porto, Portugal. (2014/05 - 2014/05)
Meeting (Member of the Organising Committee)
 Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2002/05 - 2002/05 Organizer of the XI Edition Porto Cancer Meeting “Familial and hereditary gastric cancer – Meeting of the International Gastric Cancer Linkage Consortium (IGCLC)”. IPATIMUP; Porto, Portugal. (2002/05 - 2002/05)
Meeting (Member of the Organising Committee)
 Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2023 Invited Jury member (examiner): PhD Dissertation of Marta Cardoso, ICBAS, Portugal
(Thesis) Arguer
 Marta Cardoso (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023 Invited Jury member (examiner): Masters Dissertation of João Nogueira, Univ. of Minho, Portugal
(Thesis) Main arguer
 João Nogueira (Master)
Universidade do Minho, Portugal
2023 Invited Jury member (examiner): Masters Dissertation of Cláudia Fernandes, FCUP/ICBAS, Portugal
(Thesis) Main arguer
 Cláudia Fernandes (Master)
Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022 Invited Jury member: Ph.D. Thesis of Miguel Silva, ICBAS, Portugal
(Thesis) Arguer
 Miguel Silva (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022 Member of the Ph.D. Dissertation Committee of Joana Teixeira, ICBAS, Portugal
(Thesis) Arguer
 Joana Teixeira (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022 Invited Jury member (examiner): Masters Dissertation of Patrícia Carvalho, ICBAS, Portugal
(Thesis) Arguer
 Patricia Carvalho (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022 Invited Jury member: Masters Dissertation of Marco Cruz, ICBAS, Portugal
(Thesis) Arguer
 Marco Cruz (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 Member of the Ph.D. Dissertation Committee of Abel Sousa, FCUP, Portugal
Supervisor
 Abel Sousa (PhD)
Universidade do Porto Faculdade de Ciências, Portugal
2021 Member of the Ph.D. Dissertation Committee of Daniel Ferreira, ICBAS, Portugal
Supervisor
 Daniel Ferreira (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021 Member of the Masters Dissertation Committee of Francisco Almeida, FCUP, Portugal
Supervisor
 Francisco Almeida (Master)
Universidade do Porto Faculdade de Ciências, Portugal
2021 Invited Jury member (examiner): Masters Dissertation of Ana Abreu, Univ. Aveiro, Portugal
(Thesis) Arguer
 Ana Abreu (Master)
Universidade de Aveiro, Portugal
2021 Invited Jury member (examiner): Ph.D. Thesis of Joana Maia, ICBAS, Portugal
(Thesis) Arguer
 Joana Maia (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 Member of the Ph.D. Dissertation Committee of Sara Rocha, ICBAS, Portugal; Biotechnology
Supervisor
 Sara Rocha (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020 Member of the Ph.D. Dissertation Committee of Carla Pereira, FMUP, Portugal
Supervisor
 Carla Pereira (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2019 Member of the Ph.D. Dissertation Committee of Bianca Lourenço, FEUP, Portugal; Nanomedicine
Supervisor
 Bianca Lourenço (PhD)
Universidade do Porto Faculdade de Engenharia, Portugal
2019 Member of the Ph.D. Dissertation Committee of Mafalda Matos, FMUL, Portugal; Oncobiology
Supervisor
 Mafalda Matos (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
2018 Invited Jury member (examiner): Ph.D. Thesis of Ricardo Pais, IGC, Portugal; Computational Biology
(Thesis) Arguer
 Ricardo Pais (PhD)
Instituto Gulbenkian de Ciência, Portugal
2018 Member of the Masters Dissertation Committee of Ana Rita Matos, Univ. Porto, Portugal; Gene Regulation
Supervisor
 Ana Rita Matos (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2018 Member of the Masters Dissertation Committee of Sara Teles, Univ. Porto, Portugal; Oncobiology
Supervisor
 Sara Teles (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018 Member of the Ph.D. Dissertation Committee of Joana Nunes. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Joana Nunes (PhD)
Universidade do Porto, Portugal
2018 Member of the Masters Dissertation Committee of Rafaela Silva, Univ. Porto, Portugal; Human Genetics
Supervisor
 Rafaela Silva (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2018 Invited Jury member (examiner): Masters Dissertation of Bárbara Alves. Univ. Porto, Portugal; Biology
(Thesis) Main arguer
 Bárbara Alves (Master)
Universidade do Porto, Portugal
2018 Invited Jury member (examiner): Ph.D. Thesis of Joana Lima. Univ. Porto, Portugal; Nanomedicine
(Thesis) Arguer
 Joana Lima (PhD)
Universidade do Porto, Portugal
2017 Invited Jury member (examiner): Masters Dissertation of Ricardo Cunha. Univ. Porto, Portugal; Biology
(Thesis) Main arguer
 Ricardo Cunha (Master)
Universidade do Porto, Portugal
2017 Member of the Masters Dissertation Committee of Celina São José. Univ. Porto, Portugal; Human Genetics
Supervisor
 Celina São José (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2017 Invited Jury member (examiner): Ph.D. Dissertation of Ana Metelo. Univ. Coimbra, Portugal; Biology
(Thesis) Arguer
 Ana Metelo (PhD)
Universidade de Coimbra, Portugal
2017 Invited Jury member (Pre-examiner): Ph.D. Thesis of Elisa Lazaro Ibanez. Univ. Helsinki; Biology
(Thesis) Arguer
 Elisa Lazaro Ibanez (PhD)
Helsingin yliopisto, Finland
2017 Member of the Ph.D. Dissertation Committee of Ana Sofia Varanda. Univ. Aveiro, Portugal; Biology
Supervisor
 Ana Sofia Varanda (PhD)
Universidade de Aveiro, Portugal
2016 Member of the Masters Dissertation Committee of Ana Aguiar. Univ. Porto, Portugal; Human Genetics
Supervisor
 Ana Aguiar (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2016 Invited Jury member (examiner): Ph.D. Dissertation of Suellen Ferro. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Suellen Ferro (PhD)
Universidade do Porto, Portugal
2015 Invited Jury member (examiner): Masters Dissertation of Diana Pinto. Univ. Porto, Portugal; Biology
(Thesis) Main arguer
 Diana Pinto (Master)
Universidade do Porto, Portugal
2015 Invited Jury member (examiner): Masters Dissertation of Rita Faria. Univ. Porto, Portugal; Gene Regulation
(Thesis) Main arguer
 Rita Faria (Master)
Universidade do Porto, Portugal
2015 Member of the Ph.D. Dissertation Committee of Bruno Albuquerque. Univ. Porto, Portugal; Gene Regulation
(Thesis) Arguer
 Bruno Albuquerque (PhD)
Universidade do Porto, Portugal
2015 Member of the Ph.D. Dissertation Committee of João Curado e Silva. Univ. Porto, Portugal; Bioinformatics
(Thesis) Arguer
 João Curado Silva (PhD)
Universidade do Porto, Portugal
2015 Member of the Ph.D. Dissertation Committee of Joana Santos. Univ. Porto, Portugal; Biology
(Thesis) Arguer
 Joana Santos (PhD)
Universidade do Porto, Portugal
2015 Member of the Masters Dissertation Committee of Pedro Queirós. Univ. Porto, Portugal; Oncobiology
Supervisor
 Pedro Queirós (Master)
Universidade do Porto, Portugal
2015 Member of the Ph.D. Dissertation Committee of Margherita Francescatto. Univ. Porto, Portugal; Biology
(Thesis) Arguer
 Margherita Francescatto (PhD)
Universidade do Porto, Portugal
2014 Member of the Ph.D. Dissertation Committee of Germana Domingues. Univ. Lisbon, Portugal; Biology
(Thesis) Arguer
 Germana Domingues (PhD)
Universidade Autónoma de Lisboa, Portugal
2014 Invited Jury member (examiner): Ph.D. Dissertation of Joana Costa. Univ. Lisbon, Portugal; Biology
(Thesis) Main arguer
 Joana Costa (PhD)
Universidade Autónoma de Lisboa, Portugal
2014 Member of the Ph.D. Dissertation Committee of Irina Amorim. Univ. Porto, Portugal; Glycobiology
(Thesis) Arguer
 Irina Amorim (PhD)
Universidade do Porto, Portugal
2014 Invited Jury member (examiner): Masters Dissertation of João Coentro. Univ. Porto, Portugal; Bioinformatics
(Thesis) Main arguer
 João Coentro (Master)
Universidade do Porto, Portugal
2014 Member of the Masters Dissertation Committee of Inês Reis. Univ. Porto, Portugal; Oncobiology
Supervisor
 Inês Reis (Master)
Universidade do Porto, Portugal
2014 Invited Jury member (examiner): Masters Dissertation of Rui Barranha. Univ. Porto, Portugal; Oncobiology
(Thesis) Main arguer
 Rui Barranha (Master)
Universidade do Porto, Portugal
2014 Invited Jury member (examiner): Ph.D. Dissertation of Ana Ramos. Univ. Coimbra, Portugal; Biology
(Thesis) Arguer
 Ana Ramos (PhD)
Universidade do Porto, Portugal
2013 Member of the Ph.D. Dissertation Committee of Bruno Pereira. Univ. Porto, Portugal
(Thesis) Arguer
 Bruno Pereira (PhD)
Universidade do Porto, Portugal
2013 Invited Jury member (examiner): Ph.D. Dissertation of Pedro Costa. Univ. Coimbra, Portugal; Oncobiology
(Thesis) Main arguer
 Pedro Costa (PhD)
Universidade de Coimbra, Portugal
2013 Member of the Ph.D. Dissertation Committee of Renata Bordeira-Carriço. Univ. Porto, Portugal; Human Genetics
Supervisor
 Renata Bordeira-Carriço (PhD)
Universidade do Porto, Portugal
2013 Invited Jury member (examiner): Ph.D. Dissertation of Cristovão Sousa. L’Université Pierre et Marie Curie. Paris, France; Biology
(Thesis) Main arguer
 Cristovão Sousa (PhD)
Sorbonne Université Campus Pierre et Marie Curie, France
2012 Member of the Ph.D. Dissertation Committee of Joana Carvalho. Univ. Porto, Portugal; Oncobiology
Supervisor
 Joana Carvalho (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2012 Invited Jury member (examiner): Masters Dissertation of Diana Sobral Mesquita. Univ. Porto, Portugal; Biology
(Thesis) Arguer
 Diana Sobral Mesquita (Master)
Universidade do Porto, Portugal
2012 Member of the Masters Dissertation Committee of Mafalda Azevedo. Univ. Porto, Portugal; Biology
Supervisor
 Mafalda Azevedo (Master)
Universidade do Porto, Portugal
2012 Invited Jury member (examiner): Ph.D. Dissertation of Inês Almeida. ICVS - Universidade do Minho. Braga, Portugal; Oncobiology
(Thesis) Main arguer
 Inês Almeida (PhD)
Universidade do Minho, Portugal
2012 Invited Jury member (examiner): Ph.D. Dissertation of Fatiha Sangar. L’Université Pierre et Marie Curie. Paris, France; Oncobiology
(Thesis) Main arguer
 Fatiha Sangar (PhD)
Sorbonne Université Campus Pierre et Marie Curie, France
2012 Member of the Ph.D. Dissertation Committee of Giovanni Corso. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Giovanni Corso (PhD)
Universidade do Porto, Portugal
2012 Invited Jury member (examiner): Ph.D. Dissertation of Joana Domingues. Univ. Porto, Portugal; Gene Regulation
(Thesis) Arguer
 Joana Domingues (PhD)
Universidade do Porto, Portugal
2011 Invited Jury member (examiner): Ph.D. Dissertation of Bruno Cardoso. Univ. Lisbon, Portugal; Oncobiology
(Thesis) Main arguer
 Bruno Cardoso (PhD)
Universidade Autónoma de Lisboa, Portugal
2011 Member of the Ph.D. Dissertation Committee of Hugo Pinheiro. Univ. Porto, Portugal; Human Genetics
Supervisor
 Hugo Pinheiro (PhD)
Universidade do Porto, Portugal
2011 Member of the Ph.D. Dissertation Committee of Joana Fernandes. Univ. Porto, Portugal; Biology
(Thesis) Arguer
 Joana Fernandes (PhD)
Universidade do Porto, Portugal
2011 Member of the Ph.D. Dissertation Committee of Denisa Mateus. Univ. Aveiro, Portugal; Biology
(Thesis) Main arguer
 Denisa Mateus (PhD)
Universidade de Aveiro, Portugal
2010 Invited Jury member (examiner): Masters Dissertation of Rita Domingues. Univ. Porto, Portugal; Gene Regulation
(Thesis) Arguer
 Rita Domingues (Master)
Universidade do Porto, Portugal
2010 Member of the Ph.D. Dissertation Committee of Sérgia Velho. Univ. Porto, Portugal; Oncobiology
Supervisor
 Sérgia Velho (PhD)
Universidade do Porto, Portugal
2010 Member of the Ph.D. Dissertation Committee of Sónia Melo. Univ. Porto, Portugal; Oncobiology
Supervisor
 Sónia Melo (PhD)
Universidade do Porto, Portugal
2009 Invited Jury member (examiner): Masters Dissertation of Filipa Sousa. Univ. Porto, Portugal; Human Genetics
Supervisor
 Filipa Sousa (Master)
Universidade do Porto, Portugal
2009 Member of the Ph.D. Dissertation Committee of Joana Simões-Correia. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Joana Simões-Correia (PhD)
Universidade do Porto, Portugal
2009 Member of the Ph.D. Dissertation Committee of Ana Rita Mateus. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Ana Rita Mateus (PhD)
Universidade do Porto, Portugal
2008 Invited Jury member (examiner): Ph.D. Dissertation of Ana Paula Elias. Univ. Lisbon, Portugal; Oncobiology
(Thesis) Main arguer
 Ana Paula Elias (PhD)
Universidade Autónoma de Lisboa, Portugal
2008 Member of the Ph.D. Dissertation Committee of Rachid Karam. Univ. Porto, Portugal; Human Genetics
Supervisor
 Rachid Karam (PhD)
Universidade do Porto, Portugal
2007 Invited Jury member (examiner): Masters Dissertation of Renata Carriço. Univ. Lisbon, Portugal; Human Genetics
(Thesis) Main arguer
 Renata Carriço (Master)
Universidade Autónoma de Lisboa, Portugal
2007 Member of the Ph.D. Dissertation Committee of Catarina Castro Alves. Univ. Porto, Portugal; Oncobiology
(Thesis) Arguer
 Catarina Castro Alves (PhD)
Universidade do Porto, Portugal

Association member

Society Organization name Role
2017 - Current Sociedade Portuguesa de Genética - SPG Member
2016 - Current European Society for Medical Oncology – ESMO Member
2014 - Current Portuguese Association for Cancer research – ASPIC Member
2014 - Current Grupo Español de Investigation en Vesículas Extracelulares - GEIVEX Member
2014 - Current European Association for Cancer research – EACR Member
2013 - Current European Society of Human Genetics – ESHG Deputy Secretary General and Scientific Program Committee member
2003 - Current Portuguese Society of Human Genetics - SPGH Chair of the Scientific Program Committee

Committee member

Activity description
Role 		Institution / Organization
2023 - Current Vice-representative of Centro Hospitalar Universitário S. João (CHUSJ, Porto, PT) ERN-GENTURIS (European Reference Network on Tumour Risk Syndromes)
Coordinator
 GENTURIS - European Reference Network (ERN), Netherlands
2023 - Current Member, Travel Fellowships Committee, European Association for cancer Research (EACR) European Association For Cancer Research, United Kingdom
2022 - Current Organizing Committee Member, INTERNATIONAL GASTRIC CANCER CONGRESS 2022 https://gastriccancerconference.com/general-information/committees/
Member
 International Gastric Cancer Association, United States
2022 - Current Co-Responsible of three curricular units, Degree in Digital Health and Biomedical Innovation, FMUP, UP, PT Universidade do Porto Faculdade de Medicina, Portugal
2021 - Current Review Panel Member, Research grants Bolsa Terry Fox – Liga Portuguesa contra o cancro, PT Liga Portuguesa Contra o Cancro, Portugal
2017 - Current Editorial Board member, Applied Cancer Research, BMC-Springer Nature Biomed Central Ltd, United Kingdom
2016 - Current Working Group Member, ClinGen Genomic Clinical Variant Expert Curation Panel for CDH1 gene | www.clinicalgenome.org/working-groups/clinical-domain/sub-groups/cancer/cdh1-expert-panel/ Clinical Genome Resource, United Kingdom
2014 - Current Founding Member and National Representative, European Reference Network on “ERN Genetic tumour risk syndromes - GENTURIS” | www.genturis.eu Genetic Tumour Risk Syndrome, Netherlands
2023 - 2026 Member of the Scientific Advisory Board – 2nd mandate, Integrated Cancer Research Site (Siric) Curamus, Sorbonne Université, Paris, FR Association Sorbonne Université, France
2022 - 2025 President, SPGH – Portuguese Society of Human Genetics | http://spgh.net/ Sociedade Portuguesa de Genética Humana, Portugal
2024 - 2024 Local host and Scientific Committee Member, HUGO 15th International Symposium of Variants in the Genome, 13-15 May 2024, Porto, PT| https://isv.variome.org Human Genome Organisation, United States
2024 - 2024 Co-chair of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting, 13-15 June 2024, Porto, PT | https://www.i3s.up.pt/event.php?v=304
Coordinator
 Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2022 - 2022 Coordinator of the Evaluation Panel on Experimental Biology and Biochemistry for PhD studentships selection, Portuguese Foundation for Science and technology, PT
2021 - 2022 Member of the Portuguese Group of Hereditary Tumours (PROGO) promoted by The Portuguese Society of Oncology Sociedade Portuguesa de Oncologia, Portugal
2017 - 2022 Scientific Programme Committee Member, ESHG | https://www.eshg.org/spc.0.html European Society of Human Genetics, Austria
2017 - 2020 Scientific Programme Committee Member, XLI Jornadas Portuguesas de Genética SPG | https://jornadasgenetica17.wixsite.com/ibimed/committees Sociedade Portuguesa de Genética, Portugal
2019 - 2019 Member of the Scientific Advisory Board, Integrated Cancer Research Site (Siric) Curamus Sorbonne Université, France
2018 - 2019 Member of the Committee for the Implementation of European Reference Centers in Portugal, Appointed by the Portuguese Ministry of Health Ministério da Saúde, Portugal
2018 - 2018 Scientific Committee Member, ASPIC - 3rd ASPIC International Congress | http://3rdcongress.aspic.pt/congress-commitees Associação Portuguesa de Investigação em Cancro, Portugal
2017 - 2018 Faculty member, Cancer Genetics group, European Society for Medical Oncology ESMO European Society for Medical Oncology, Switzerland
2017 - 2017 Faculty member, Inherited Cancer, 25th United European Gastroenterology Week 2017 United European Gastroenterology, Austria
2017 - 2017 Scientific Committee Member, Conference “Risco Familiar de Cancro” | www.ligacontracancro.pt/risco-familiar-de-cancro Liga Portuguesa Contra o Cancro, Portugal
2017 - 2017 Scientific Committee Member, SINAL 2017 8th Meeting on Signal Transduction Associação Portuguesa de Investigação em Cancro, Portugal
2015 - 2017 Scientific Committee Member, Grupo Español Investigación Vesículas Extracelulares, GEIVEX Grupo Español de investigacion en Vesiculas Extracelulares, Spain
2014 - 2014 Scientific Committee Member, ASPIC | 1st ASPIC International Congress Associação Portuguesa de Investigação em Cancro, Portugal

Consulting

Activity description Institution / Organization
2002 - Current PEER REVIEW JOURNALS: Journal of Pathology; Oncogene; BMC Cancer; Annals of Human Genetics; European Journal of Human Genetics; Cellular Oncology; Familial Cancer; Future Oncology; Clinical Genetics; European Journal of Cancer; International Journal of Cancer; Carcinogenesis; Virchows Archives; World journal of Gastroenterology; Epigenomics; PlosOne; BMC Genomics; Human Molecular Genetics; Genome Research; Lancet Oncology; Gastroenterology; Frontiers in Genetics; Journal of Medical Genetics
2002 - Current FUNDING AGENCIES: Health Research Council of New Zealand; European Research Council Executive Agency; ICS-Institut Clinique de la Souris, France; Dutch Cancer Society (KWF Kankerbestrijding); Portuguese Foundation of Science and Technology (FCT): Research Projects, PhD and Post-doc grant applications (http://www.fct.pt /apoios/bolsas/concursos/ membros?idc=28&idav=38&idp={8AB5E1CF-5699-4213-966A-C2E899921CB0}&show=elems)

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022 - Current Responsible for the curricular unit "Biomedical and Bioinformatics Research I" in the 1st Degree in Digital Health and Biomedical Innovation from FMUP, Univ. Porto, Porto PT (Licenciatura) Universidade do Porto Faculdade de Medicina, Portugal
2022 - Current Co-responsible for the curricular unit "Biomedical and Bioinformatics Research II" in the 1st Degree in Digital Health and Biomedical Innovation from FMUP, Univ. Porto, Porto PT (Licenciatura) Universidade do Porto Faculdade de Medicina, Portugal
2022 - Current Co-responsible for the curricular unit "Project in Human Biology" in the 1st Degree in Digital Health and Translational Medicine from FMUP, Univ. Porto, Porto PT (Licenciatura) Universidade do Porto Faculdade de Medicina, Portugal
2019 - Current Faculty and Supervisor, PhD Programme in Business Administration, Univ. Minho, Braga, PT (Doutoramento) Universidade do Minho, Portugal
2019 - Current Faculty and Supervisor, Doctoral Program in Molecular and Cell Biology (MCbiology), ICBAS, Univ. Porto, PT (Doutoramento) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - Current Faculty and co-Organizer, European Society of Human Genetics-ESHG Biennial Course in Hereditary Cancer Genetics, Univ. Residential Centre Bertinoro, IT (Outros) European Society of Human Genetics, Austria
2014 - Current Faculty and Supervisor, BiotechHealth - Doctoral Program on Cellular and Molecular Biotechnology Applied to Health Sciences, Porto, PT (Doutoramento) BiotechHealth Programme, Portugal
2011 - Current Faculty, Ipatimup, “Genomics and Transcriptomics”, Workshop in Cancer Research. Porto, PT (Outros) Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
2008 - Current Faculty and Supervisor, Oncology Master Program, ICBAS, Porto, PT (Mestrado) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2005 - Current Faculty and Supervisor, Doctoral Program in Molecular Medicine and Oncology (PDMOM), FMUP, Univ. Porto, PT (Doutoramento) Universidade do Porto Faculdade de Medicina, Portugal
2005 - Current Faculty and Supervisor, Medicine and Molecular Oncology Master (MOM) Program, FMUP, Porto, PT (Mestrado) Universidade do Porto Faculdade de Medicina, Portugal
2005 - Current Faculty and Supervisor, Biomedicine Doctoral Program, FMUP, Porto, PT (Doutoramento) Universidade do Porto Faculdade de Medicina, Portugal
2004 - Current Faculty and Supervisor, GABBA PhD Program, Univ. Porto, PT (Doutoramento) Universidade do Porto, Portugal
2017 - 2019 Faculty and Supervisor, Bioinformatics Master Program, Univ. Minho, Braga, PT (Mestrado) Universidade do Minho, Portugal
1995 - 1996 Monitor (volunteer), practical lessons of Molecular Biology delivered to of Biochemistry and Biology undergraduate students (Curso de Especialização Tecnológica) Universidade de Coimbra, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2022 - Current Coordinator of the Evaluation Panel on Experimental Biology and Biochemistry for PhD studenships selection, Portuguese Foundation for Science and technology
Coordinator
 Fundação para a Ciência e a Tecnologia, Portugal Fundação para a Ciência e a Tecnologia
2022 - Current Coordinator of the Evaluation Panel on Experimental Biology and Biochemistry for PhD studentships selection, Portuguese Foundation for Science and technology, PT
Evaluator
 Fundação para a Ciência e a Tecnologia, Portugal Fundação para a Ciência e a Tecnologia
2022 - Current Co-Responsible of three curricular units, Degree in Digital Health and Biomedical Innovation, FMUP, UP, PT Universidade do Porto Faculdade de Medicina, Portugal Universidade do Porto Faculdade de Medicina
2021 - Current Review Panel Member, Research grants Bolsa Terry Fox - Liga Portuguesa contra o cancro, PT
Member
 Liga Portuguesa Contra o Cancro, Portugal Liga Portuguesa Contra o Cancro
2019 - Current Review Panel Member of research grant: Swiss Cancer League Grant, CH; French National Cancer Institute (INCa), FR
Specialist
 Institut National du Cancer, France Institut National du Cancer
2018 - Current Review Panel Member of research grant: Fundo iMM-Laço Annual Research Grant, PT Instituto de Medicina Molecular João Lobo Antunes, Portugal Fundo iMM
2014 - Current Curator of the LOVD database on CDH1 variants Leiden Open Variation Database, Netherlands Leiden Open Variation Database
2014 - Current Member of the Abstract Reviewing Committee, United European Gastroenterology Week United European Gastroenterology, Austria United European Gastroenterology
2013 - Current Founding and Executive Committee Member of the Consortium GENOMEPortugal Universidade de Aveiro Instituto de Biomedicina, Portugal Fundação para a Ciência e a Tecnologia
2011 - Current Review Panel Member of research grants: New Zealand Health Research Council; ICS-Institut Clinique de la Souris, FR; Dutch Cancer Society, NL; Foundation center le Cancer, BE Institut Clinique de la Souris, France

KWF Kankerbestrijding, Netherlands

Fondation contre le Cancer, Belgium 		Fondation contre le Cancer

KWF Kankerbestrijding

Institut Clinique de la Souris
2011 - Current Scientific Evaluation Panel Member of Ph.D. and Post-doc fellowships and “Investigator FCT” applications for FCT-Portuguese Foundation of Science and Technology Associação para a Inovação e Desenvolvimento da FCT, Portugal Associação para a Inovação e Desenvolvimento da FCT
1999 - Current Founding Member of the International Gastric Cancer Linkage Consortium International Gastric Linkage Consortium (IGCLC), Portugal International Gastric Linkage Consortium (IGCLC)
2023 - 2026 Member of the Scientific Advisory Board – 2nd mandate, Integrated Cancer Research Site (Siric) Curamus, Sorbonne Université, Paris, FR Association Sorbonne Université, France Association Sorbonne Université
2022 - 2025 President, SPGH - Portuguese Society of Human Genetics | http://spgh.net/
President
 Sociedade Portuguesa de Genética Humana, Portugal Sociedade Portuguesa de Genética Humana
2024 - 2024 Local host and Scientific Committee Member, HUGO 15th International Symposium of Variants in the Genome, 13-15 May 2024, Porto, PT| https://isv.variome.org Human Genome Organisation, United States Human Genome Organisation
2024 - 2024 Co-chair of the 5th International Gastric Cancer Linkage Consortium (IGCLC) meeting, 13-15 June 2024, Porto, PT | https://www.i3s.up.pt/event.php?v=304 Universidade do Porto Instituto de Investigacao e Inovacao em Saude, Portugal
2017 - 2022 Deputy Secretary General - Executive Board ESHG - European Society of Human Genetics European Society of Human Genetics, Austria European Society of Human Genetics
2020 - 2020 Selection Committee, Tenure-track positions
Other
 Universitat de Barcelona - Campus Mundet, Spain Universitat de Barcelona
2020 - 2020 External Evaluator, La Marató de TV3 Agency for Health and Quality and Assessment of Catalonia, Spain Agency for Health and Quality and Assessment of Catalonia
2020 - 2020 External Evaluator, Research Grants
Evaluator
 Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Portugal Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.
2020 - 2020 External Evaluator, Research Grants Institut National du Cancer
Evaluator
 Institut National du Cancer, France Institut National du Cancer
2020 - 2020 ERC Remote Referee, European Research Council Executive Agency (ERCEA) for Starting Grants, Panel L4
Evaluator
 European Research Council Executive Agency, Belgium European Research Council Executive Agency
2018 - 2020 Secretary of the General Assembly, ASPIC - Portuguese Association for Cancer Research | http://www.aspic.pt/en/page/committes Associação Portuguesa de Investigação em Cancro, Portugal Associação Portuguesa de Investigação em Cancro
2017 - 2020 Chair of the Scientific Programme Committee, SPGH – Portuguese Society of Human Genetics | http://spgh.net/comissoes/comissao-cientifica/ Sociedade Portuguesa de Genética Humana: SPGH, Portugal Sociedade Portuguesa de Genética Humana: SPGH
2015 - 2017 Invited participant, Oncology at the Limits Conference Series | www.atthelimits.org/oncology Elsevier Ltd, United Kingdom Elsevier Ltd
2014 - 2017 Member of the Abstract Reviewing Committee, ESHG | https://www.eshg.org/ European Society of Human Genetics, Austria European Society of Human Genetics
2013 - 2017 Management Committee Member, BMBS COST Action BM1202 "Euro Network: Microvesicles and Exosomes in Health & Disease" | http://bit.ly/2k2bKoM European Network on Microvesicles and Exosomes in Health and Disease, Belgium European Network on Microvesicles and Exosomes in Health and Disease
2010 - 2013 Scientific Programme Committee Member, ESHG | https://www.eshg.org/spc.0.html European Society of Human Genetics, Austria European Society of Human Genetics
Distinctions

Award

2024 Honorable Mention "8th Edition Prémio Rui Osório de Castro / Millennium BCP" 2024 for the project "SAPO: Paediatric sarcomas and organoids: new diagnostic biomarkers".
2023 SPGH Meeting "Prémio Investigação Clinica 2023" for best presentation on "An Insight on the Origins of Hereditary Diffuse Gastric Cancer Through Organoid Driven Organ On-A-Chip Technology" (to Daniel Ferreira; Carla Oliveira senior author)
2023 SPGH Meeting "Prémio Investigação Básica 2023" for best presentation on "The CDH1 Regulatory Blueprint: Shaping Hereditary Diffuse Gastric Cancer" (to Celina S. José; Carla Oliveira Senior Author)
2023 Maria de Sousa Award 2023 on "Using Genome-Wide Crispr Genetic Screens to Dissect the Molecular Mechanisms Underlying Therapy Resistance and Sensitivity in Her2-Positive Gastric Cancer". Fundação Bial (to João Neto; Carla Oliveira member of the team)
2022 International 3Rs Prize – Awarded by the National Centre for the Replacement, Refinement & Reduction of Animals in Research, 2022, UK (to Daniel Ferreira and Carla Oliveira)
2022 SPGH Professor Amândio Tavares 2022 Award for the oral presentation entitled “CTNNA1 germline variants: disease spectrum extending beyond Hereditary Diffuse Gastric Cancer” (to Silvana Lobo; Carla Oliveira senior author)
2022 SPGH Meeting “ESHG National Fellowship 2022” for best presentation on “Disruption of regulatory elements in the CDH1 vicinity as a potential HDGC cause, increased penetrance and early onset cancer” (to Celina S. José; Carla Oliveira senior author)
2021 SPGH Professor Amândio Tavares 2021 Award for the oral presentation entitled “The First CDH1 Founder Variant in the Portuguese Population: A Missense with severe Impact in mRNA Splicing” (to Rita Barbosa-Matos; Carla Oliveira senior author)
2021 3rd Best Poster session from XIII National Meeting of Biochemistry Students for the project entitle "Characterization of CDH1 and its Antisense Gene in Stomach and Breast Normal Cell Lines" (to Nelson Martins; Carla Oliveira senior author)
2021 Alfredo da Silva Award 2021 on "Sustainability of Health Systems" for the project entitled "Hereditary Breast Ovarian Cancer - HBOC: Optimizing hereditary cancer pathways (saving costs and lives)" lead by Carla Oliveira.
2020 2nd National Meeting of Young Oncology Researchers 2020 “Best Oral Communication” for the oral presentation entitled “Tumor immune profile reveals a new role for regulatory T cells in the development of gastric cancer” (to Sara Rocha; Carla Oliveira senio
2019 “ESHG National Fellowship 2019” for best presentation on “The role of CDH1 regulatory noncoding elements for E-cadherin expression” (to Celina S. José; Carla Oliveira senior author)
Sociedade Portuguesa de Genética Humana: SPGH, Portugal
2019 “Mia Neri Award for the best talk in cancer research, Award 2019” for the oral presentation entitled “Structural variations at CDH1 intronic cis-regulatory elements cause CDH1/E-cadherin loss of function” (to Ana Rita Matos; Carla Oliveira senior author)
European Society of Human Genetics, Austria
2018 “ESHG National Fellowship 2018” for best oral presentation on “Intronic cis-regulatory elements regulate CDH1 gene expression and function” (to Ana Rita Matos; Carla Oliveira senior author)
Sociedade Portuguesa de Genética Humana: SPGH, Portugal
2018 “Best Poster in Clinical Practice award” for the best clinical research work in Oncogenetics and Public Services in a Poster format, 2018 (to Luzia Garrido; Carla Oliveira senior author)
European Society of Human Genetics, Austria
2017 Prof. Doutor Amândio Tavares, FWA Award for the best basic research work in Oncogenetics and Public Services
2017 V Aeicbas Biomedical Congress / ICBAS "Best Poster Award" in PT, 2017 (to Celina São José; Carla Oliveira senior author)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017 “Prof. Doutor Amândio Tavares, FWA Award” for the best basic research work in Oncogenetics and Public Services in PT, 2017 (to Luzia Garrido; Carla Oliveira senior author)
Sociedade Portuguesa de Genética Humana: SPGH, Portugal
2016 One of the 100 Portuguese female scientists featured in the Book “Mulheres na Ciência” CiênciaViva 2016.
2005 Best entry in the Winter submissions for EACR travel fellowships
European Association For Cancer Research, United Kingdom
2004 SPGH Meeting “Young Investigator Award” for best basic research work in Human Genetics in PT 2004 (to Rachid Karam; Carla Oliveira senior author)
Sociedade Portuguesa de Genética Humana, Portugal
2003 Labmed Prize for Research in health, 2003 (Carla Oliveira co-author)
LabMED Saúde, Portugal
2003 Menção Honrosa da Sociedade Portuguesa de Genetica Humana
Sociedade Portuguesa de Genética Humana, Portugal
2002 SPGH Meeting “Young Investigator Award” for best basic research work in Human Genetics in PT 2002 (to Carla Oliveira)
Sociedade Portuguesa de Genética Humana, Portugal
2001 Labmed 2nd Prize for Research in health, 2001 (Carla Oliveira co-author)
LabMED Saúde, Portugal
1998 Portuguese Rotary Club Portugal Prize for best Research work in Oncobiology in Portugal 1998 (to Carla Oliveira)